Obesity due to excess calories

E4_OBESITYCAL

obesity: A disorder involving an excessive amount of body fat.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E66.00, E66.01 Cause of death: ICD-10 — E66.00, E66.01 2 out of 7 registries used, show all original rules.	25149
4. Check minimum number of events None	25149
5. Include endpoints None	25149
6. Filter based on genotype QC (FinnGen only)	24226

Control definitions (FinnGen only)

Control exclude: E4_OBESITY

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	E4_OBESITYCAL
CONTROL_EXCLUDE	E4_OBESITY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E660
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E660
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Obesity due to excess calories based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	139360	80833	57952
Only index persons	132586	77999	54587
Unadjusted period prevalence (%)
Whole population	2.02	2.32	1.62
Only index persons	2.54	2.87	2.08
Median age at first event (years)
Whole population	48.19	45.78	51.66
Only index persons	48.20	45.67	51.81

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	24226	15910	8316
Unadjusted period prevalence (%)	5.01	5.64	3.81
Median age at first event (years)	51.86	49.05	57.25

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
25149: Matched controls
251490

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H03AA01

ATC

levothyroxine sodium; systemic

1.8

322.8

5931

36301

A08AA02

ATC

fenfluramine; oral

9.2

322.2

392

432

R03BA05

ATC

fluticasone; inhalant

1.9

319.6

4888

28217

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.8

317.2

7066

45740

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.5

316.5

2175

9180

27799

ICD-8 Finland

Obesity not specified as of endocrine origin

+∞

314.2

301

SPAT1301

SPAT

No procedures

1.7

313.2

7628

50595

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.3

312.1

2729

12807

SPAT1240

SPAT

Therapeutic discussion

2.1

310.9

3329

16933

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

7.7

310.5

437

576

C09DA01

ATC

losartan and diuretics; oral

2.3

309.8

2549

11657

J01MA12

ATC

levofloxacin; systemic

1.9

309.1

4333

24271

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.1

308.3

3380

17342

A10BJ01

ATC

exenatide; parenteral

14.5

307.7

632

447

A08

ICPC

Swelling

3.2

307.7

1377

4409

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.2

307.7

3694

18109

SPAT1263

SPAT

Sampling

1.9

307.7

11336

76193

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.3

307.7

2761

12690

C03DA01

ATC

spironolactone; oral

3.2

307.7

3458

11928

I10

ICD-10 Finland

Essential (primary) hypertension

3.2

307.7

16302

91610

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.5

307.7

3232

14178

A10BG03

ATC

pioglitazone; oral

6.3

307.7

983

1619

C09BA02

ATC

enalapril and diuretics; systemic

2.7

307.7

1847

7093

A10AE05

ATC

insulin detemir; parenteral

3.6

307.7

1814

5276

C07AB07

ATC

bisoprolol; oral

2.2

307.7

11752

71673

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.6

307.7

2567

10713

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

3063.3

307.7

2582

C08CA13

ATC

lercanidipine; oral

2.3

307.7

3428

15859

A46

ICD-10 Finland

Erysipelas

3.1

307.7

4434

16298

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

11.0

307.7

4205

4497

S18

ICPC

Laceration/cut

1.8

307.7

11035

77379

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.3

307.7

4231

20076

L15

ICPC

Knee symptom/complaint

2.0

307.7

6318

35968

RD210, ,

NOMESCO Finland

7.6

307.7

907

1239

E66.01

ICD-10 Finland

Obesity due to excess calories

258.0

307.7

19306

3180

C09AA05

ATC

ramipril; oral

1.9

307.7

5140

29585

A10BK01

ATC

dapagliflozin; oral

4.4

307.7

2709

6719

N06AX21

ATC

duloxetine; oral

2.4

307.7

3684

16632

B03BA03

ATC

hydroxocobalamin; parenteral

3.5

307.7

1503

4466

WX290

NOMESCO Finland

Other blockage of nerve

1.7

307.7

12902

96006

N06AB03

ATC

fluoxetine; oral

2.2

307.7

3541

17183

M54.4

ICD-10 Finland

Lumbago with sciatica

1.9

307.7

4895

27807

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.2

307.7

5682

30058

EBA00

NOMESCO Finland

Extraction of tooth

1.7

307.7

9303

63862

3055, ,

Kela drug reimbursment

14.7

307.7

319

219

A08AA62

ATC

bupropion and naltrexone; systemic

14.1

307.7

343

247

SPAT1249

SPAT

Treatment-related counselling outside office

1.8

307.7

10541

71994

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

6.2

307.7

773

1271

C10AA05

ATC

atorvastatin; oral

1.8

307.7

9064

59806

WX723

NOMESCO Finland

CPAP therapy

3.7

307.7

1434

4040

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.1

307.7

5586

30239

WX722

NOMESCO Finland

PEEP

5.8

307.7

1972

3659

XX_20

NOMESCO Finland

Bioimpedance measurement

40.0

307.7

214

A10BJ05

ATC

dulaglutide; parenteral

9.5

307.7

1142

1254

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.0

307.7

4619

25800

R60.0

ICD-10 Finland

Localized oedema

2.6

307.7

3352

13853

215

Kela drug reimbursment

Diabetes, non-insulin-treated

4.8

307.7

10003

30690

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

307.7

11841

81281

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

10.7

307.7

3881

4219

T82

ICPC

Obesity

14.3

307.7

3722

3021

103

Kela drug reimbursment

Diabetes, insulin-treated

4.8

307.7

10406

32204

XCK10

NOMESCO Finland

Photography of fundus of eye

2.5

307.7

2370

10142

A10BB12

ATC

glimepiride; oral

5.0

307.7

2090

4496

G47.3

ICD-10 Finland

Sleep apnoea

6.2

307.7

11554

30163

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.6

307.7

3416

14249

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

5.5

307.7

4211

8886

N03AX16

ATC

[U] pregabalin

2.1

307.7

6257

34531

R06.0

ICD-10 Finland

Dyspnoea

2.5

307.7

7648

37832

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.4

307.7

3039

13887

E66.1

ICD-10 Finland

Drug-induced obesity

80.3

307.7

286

SPAT1254

SPAT

Administration of medicine

2.2

307.7

3668

18305

OAB72

NOMESCO Finland

Weight control and weight loss guidance

32.5

307.7

892

284

160

Kela drug reimbursment

exenatide

20.0

307.7

1542

819

A02BC02

ATC

pantoprazole; systemic

2.1

307.7

17520

131391

A10BA02

ATC

metformin; oral

6.1

307.7

12305

34222

E66.9

ICD-10 Finland

Obesity, unspecified

66.1

307.7

3783

672

OAB72, ,

SPAT

8.1

307.7

645

816

E66.00

ICD-10 Finland

Metabolic syndrome

70.4

307.7

9162

2032

C10AA01

ATC

simvastatin; oral

2.0

307.7

8886

53810

JDF01

NOMESCO Finland

Laparoscopic gastroplasty

1574.4

307.7

746

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.9

307.7

7771

47147

R03AC02

ATC

salbutamol; inhalant

2.2

307.7

15607

107519

A10BK03

ATC

empagliflozin; oral

4.5

307.7

3878

9705

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

307.7

5289

30543

A10AE04

ATC

insulin glargine; parenteral

4.2

307.7

3709

9916

I50.0

ICD-10 Finland

Congestive heart failure

3.9

307.7

1611

4351

A08AA10

ATC

sibutramine; oral

23.9

307.7

277

117

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

5.4

307.7

1286

2463

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

307.7

10867

78286

K02.1

ICD-10 Finland

Caries of dentine

1.7

307.7

15643

123834

A10BH05

ATC

linagliptin; oral

4.2

307.7

1478

3661

A10AB05

ATC

insulin aspart; parenteral

3.6

307.7

2653

8065

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

24.5

307.7

866

366

WX780

NOMESCO Finland

Remote monitoring CPAP

3.7

307.7

1519

4285

C02AC05

ATC

moxonidine; oral

3.8

307.7

1311

3616

N02BE01

ATC

paracetamol; systemic, rectal

3.1

307.7

23078

196330

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

3.0

307.7

7747

32830

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

5.5

307.7

684

1266

J96.1

ICD-10 Finland

Chronic respiratory failure

6.1

307.7

615

1024

M79.6

ICD-10 Finland

Pain in limb

1.9

307.7

11151

75324

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.5

307.7

2632

11050

T83

ICPC

Overweight

5.2

307.7

980

1960

C09AA02

ATC

enalapril; systemic

2.3

307.7

4464

21269

R06.5

ICD-10 Finland

Mouth breathing

2.5

307.7

2660

11403

QBJ30

NOMESCO Finland

Correction of abdominal apron

35.1

307.7

855

252

N02AX02

ATC

tramadol; systemic, rectal

2.3

307.7

11996

71785

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

8.6

307.7

3212

4205

SPAT1262

SPAT

Handing over of treatment supplies

3.8

307.7

6489

21238

E66

ICD-10 Finland

Obesity

12.1

307.7

4265

4186

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.3

307.7

8123

42458

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

5.8

307.7

10048

25767

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.4

307.7

4253

19849

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

8.5

307.7

590

708

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.3

307.7

3152

14696

N06AX12

ATC

bupropion; oral

2.6

307.7

2482

10277

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

+∞

307.7

325

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

3.1

307.7

4175

15364

R4190

NOMESCO Finland

Nutritional therapy

5.8

307.7

1861

3400

3051, ,

Kela drug reimbursment

12.4

307.7

679

561

L17

ICPC

Foot/toe symptom/complaint

1.9

307.7

7382

45570

205

Kela drug reimbursment

Chronic hypertension

3.0

307.7

6945

28604

R5140

NOMESCO Finland

Monitoring the use of the aid

5.1

307.7

5042

11855

J01AA02

ATC

doxycycline; systemic

1.8

307.7

19069

160028

J01DB01

ATC

cefalexin; oral

2.4

307.7

21669

182412

162

Kela drug reimbursment

liraglutide

19.7

307.7

806

423

S97

ICPC

Chronic ulcer skin

3.5

307.7

1717

5096

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

307.7

11337

77675

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.3

307.7

3998

19404

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

3.2

307.7

3227

11135

M10.9

ICD-10 Finland

Gout, unspecified

3.6

307.7

1919

5638

H02AB06

ATC

prednisolone; systemic

1.9

307.7

12351

84257

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

3.8

307.7

4743

14597

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

394.0

307.7

1057

L03

ICPC

Low back symptom/complaint

1.8

307.7

7319

46926

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.7

307.7

14412

111993

358

Kela drug reimbursment

liraglutide

18.9

307.7

337

181

R02

ICPC

Shortness of breath/dyspnoea

2.4

307.7

3583

16436

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.7

307.7

3730

15210

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.2

307.7

4009

20365

N05AH04

ATC

quetiapine; oral

2.1

307.7

5141

27417

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

307.7

11416

73020

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

7.1

307.7

2094

3161

N03AX12

ATC

[U] gabapentin; oral

2.1

307.7

4299

22717

J45.9

ICD-10 Finland

Asthma, unspecified

2.6

307.7

5866

26593

B01AA03

ATC

warfarin; systemic

2.2

307.7

3642

18137

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.6

307.7

3259

13647

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.7

307.7

3503

14338

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

5.9

307.7

960

1685

N06AB04

ATC

citalopram; systemic

2.0

307.7

5698

31835

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

4.2

307.7

1225

3042

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.2

307.7

1395

4476

WX110

NOMESCO Finland

Infiltration anesthesia

1.9

307.7

18760

152610

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.6

307.7

2542

10459

XG466

NOMESCO Finland

Sleep oxymetry

6.1

307.7

1298

2226

E66.8

ICD-10 Finland

Other obesity

114.4

307.7

7082

859

A10AC01

ATC

insulin (human); parenteral

3.6

307.7

2496

7426

A08AB01

ATC

orlistat; oral

27.6

307.7

524

194

A10BJ06

ATC

semaglutide; parenteral

9.9

307.7

3353

3843

207

Kela drug reimbursment

Chronic arrhythmias

2.2

307.7

3026

14525

A10BJ02

ATC

liraglutide; parenteral

14.9

307.7

2283

1679

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.0

307.7

5102

27931

J01DA01

ATC

[U] cefalexin

1.7

307.7

15420

121918

R03BB04

ATC

tiotropium bromide; inhalant

2.5

307.7

2343

9992

I50.9

ICD-10 Finland

Heart failure, unspecified

3.6

307.7

3224

9892

E66.0

ICD-10 Finland

Obesity due to excess calories

786.1

307.7

1687

A10BX04

ATC

[U] exenatide

21.4

307.7

735

354

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

307.7

5269

27190

C03AA03

ATC

hydrochlorothiazide; oral

3.0

307.7

2301

8114

C03CA01

ATC

furosemide; systemic

3.8

307.7

8523

29871

N06AX16

ATC

venlafaxine; oral

2.2

307.7

4504

22313

SPAT1310

SPAT

Counselling related to known health issue

1.8

307.7

8388

53572

M04AA01

ATC

allopurinol; systemic

3.6

307.7

3727

11661

T90

ICPC

Diabetes non-insulin dependent

4.6

307.7

9328

28316

C08CA01

ATC

amlodipine; oral

2.2

307.7

9163

51797

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.8

307.7

7934

51153

A10BX07

ATC

[U] liraglutide

21.2

307.7

956

467

A10BD07

ATC

metformin and sitagliptin; systemic

3.8

307.7

1324

3601

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

4.2

307.7

1188

2940

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.9

307.7

7236

43291

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

5.8

307.7

620

1093

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.2

307.7

3133

15306

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.2

307.7

3516

17014

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.1

307.7

3638

13033

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.3

307.7

5498

26789

C09CA01

ATC

losartan; oral

1.9

307.7

5774

33925

A10BH01

ATC

sitagliptin; oral

4.9

307.7

3762

8699

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

6.4

307.7

1174

1904

L28

ICPC

Limited function/disability (L)

2.3

307.7

4132

20017

E11

ICD-10 Finland

Type 2 diabetes mellitus

4.3

307.7

6020

17036

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.8

307.7

3648

14212

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

3.9

307.7

5502

16652

J01FF01

ATC

clindamycin; systemic

2.1

307.7

7614

43483

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

5.2

307.7

937

1873

B01AB05

ATC

enoxaparin; parenteral

2.4

307.7

8970

47211

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

4.4

307.7

843

1953

M54.5

ICD-10 Finland

Low back pain

1.9

307.7

10018

64435

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.1

306.3

3229

16320

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.8

305.3

5687

34866

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

301.1

9542

67707

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.7

300.3

8002

54254

C07AB02

ATC

metoprolol; systemic

2.0

298.4

4083

22656

P06

ICPC

Sleep disturbance

2.1

294.2

3358

17468

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.6

292.4

1898

7788

SGA01

NOMESCO Finland

Emergency treatment

1.9

292.1

4673

27282

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.9

291.2

1466

5284

S76

ICPC

Skin infection other

2.9

289.2

1484

5404

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

288.8

5736

35758

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.9

287.8

4469

25829

J45.1

ICD-10 Finland

Nonallergic asthma

2.5

285.2

1951

8203

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.2

284.0

2781

13635

I50

ICD-10 Finland

Heart failure

4.7

282.4

670

1463

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.4

280.6

2001

8574

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

4.6

280.1

686

1537

ACC51

NOMESCO Finland

Release of median nerve

2.4

279.5

2109

9269

SPAT1139

SPAT

Nutrition survey

3.5

277.9

985

2881

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.6

277.7

960

2762

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.1

277.3

2944

14883

N05AX12

ATC

aripiprazole; systemic

2.9

274.8

1331

4694

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

273.8

3262

17202

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.1

271.2

1206

4052

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.7

270.7

6545

42997

K07

ICPC

Swollen ankles/oedema

3.2

269.3

1090

3464

P76

ICPC

Depressive disorder

2.4

269.3

2097

9340

N05BA04

ATC

oxazepam; oral

1.7

267.7

6394

41844

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

267.6

12164

93361

M10

ICD-10 Finland

Gout

3.2

265.5

1114

3617

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

265.4

5186

32067

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

264.8

4586

27351

M79.7

ICD-10 Finland

Fibromyalgia

3.1

263.9

1172

3934

M25.5

ICD-10 Finland

Pain in joint

1.6

263.0

8170

57184

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.8

262.4

1349

4912

C01DA14

ATC

isosorbide mononitrate; oral

2.2

261.8

2535

12353

SPAT1229

SPAT

Assessment of need for aid

2.5

260.7

1733

7180

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

260.4

2826

14385

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

259.9

13280

104435

K04.0

ICD-10 Finland

Pulpitis

2.1

259.8

2789

14139

SPAT1312

SPAT

General health counselling

1.6

259.7

8041

56193

A10BB01

ATC

glibenclamide; oral

4.2

259.3

699

1687

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

259.2

2841

14514

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

258.6

9554

69669

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.6

257.9

1563

6192

A10AD05

ATC

insulin aspart; parenteral

6.0

257.1

456

768

P01AB01

ATC

metronidazole; oral, rectal

1.6

256.8

10062

74360

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.4

255.7

973

2976

B01AF02

ATC

apixaban; oral

2.2

255.3

2480

12094

P03

ICPC

Feeling depressed

2.0

254.6

3004

15760

SFA30

NOMESCO Finland

Three-surface restoration

1.6

254.0

10419

77760

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

253.8

2402

11593

Z02.7

ICD-10 Finland

Issue of medical certificate

2.4

253.2

1889

8248

R60.9

ICD-10 Finland

Oedema, unspecified

2.7

252.6

1423

5434

SPAT1260

SPAT

Consultation of another employee

1.8

252.5

4372

26032

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.2

252.2

2467

12062

B81

ICPC

Anaemia vit B12/folate deficiency

3.4

250.4

941

2855

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.5

250.2

1739

7352

N06AB10

ATC

escitalopram; oral

1.7

250.2

5636

36194

J45

ICD-10 Finland

Asthma

2.1

249.6

2781

14283

A28

ICPC

Limited function/disability NOS

2.0

248.5

3064

16319

M10.0

ICD-10 Finland

Idiopathic gout

3.6

248.2

850

2429

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

247.3

6246

41342

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

4.3

246.8

656

1566

A10BG02

ATC

rosiglitazone; oral

6.3

246.1

420

681

SFA20

NOMESCO Finland

Two-surface restoration

1.6

246.0

15031

122408

J01CE08

ATC

benzathine benzylpenicillin; parenteral

6.8

245.5

386

575

R03BA02

ATC

budesonide; inhalant

1.8

244.5

4484

27136

S10

ICPC

Boil/carbuncle

2.5

243.4

1607

6631

R96

ICPC

Asthma

2.1

243.1

2452

12124

M48.0

ICD-10 Finland

Spinal stenosis

2.1

240.7

2559

12905

SFA10

NOMESCO Finland

One-surface restoration

1.5

238.5

13975

112382

N02AA05

ATC

oxycodone; systemic

1.9

237.2

3514

19888

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.2

237.2

2098

9841

SPAT1211

SPAT

Application of soft bandage

2.2

236.5

2186

10439

C09DA06

ATC

candesartan and diuretics; oral

2.4

234.0

1806

7996

J46

ICD-10 Finland

Status asthmaticus

3.5

233.3

847

2513

W84

ICPC

Pregnancy high risk

2.8

233.2

1216

4457

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

233.0

5902

38995

R03DC03

ATC

montelukast; oral

1.8

233.0

4296

26001

OAB50, ,

SPAT

2.6

232.7

1456

5852

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.8

231.7

3831

22433

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

4.5

230.9

580

1325

A10BH02

ATC

vildagliptin; oral

4.8

230.8

533

1138

J01FA06

ATC

roxithromycin; oral

1.6

230.2

9390

69528

L90

ICPC

Osteoarthrosis of knee

2.5

230.0

1546

6429

Z3231

NOMESCO Finland

Registered nurse

1.6

229.1

6299

42471

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.8

228.2

1210

4473

M01AB05

ATC

diclofenac; systemic, rectal

1.6

227.7

16125

134515

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.6

225.8

1399

5595

C09CA03

ATC

valsartan; oral

2.2

225.5

2071

9856

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.3

225.3

1794

8046

M03BX02

ATC

tizanidine; oral

1.5

224.7

15581

129175

WZC30

NOMESCO Finland

Teaching

1.8

224.7

3723

21797

O36.6

ICD-10 Finland

Maternal care for excessive fetal growth

2.9

224.5

1119

4002

R05FB02

ATC

cough suppressants and expectorants; systemic

1.6

224.0

8189

59055

A10BD03

ATC

metformin and rosiglitazone; systemic

5.6

223.2

429

780

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

223.1

3447

19744

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

222.9

3106

17205

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

222.9

5304

34417

N06AB06

ATC

sertraline; oral

1.9

222.6

3089

17087

M01AH05

ATC

etoricoxib; oral

1.5

222.3

15187

125354

N06AX11

ATC

mirtazapine; oral

1.6

221.9

8101

58370

N06AA09

ATC

amitriptyline; systemic

2.1

221.7

2235

11030

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

221.5

4636

29048

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.8

220.0

701

1907

O24.1

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent

8.7

219.4

277

320

A02BC01

ATC

omeprazole; systemic

1.6

219.0

6206

42079

C09CA06

ATC

candesartan; oral

1.7

218.7

5512

36279

SPAT1216

SPAT

Assessment of functional ability

1.9

218.6

3113

17360

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

218.3

18349

158241

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

217.7

3238

18313

A10BX01

ATC

guar gum; oral

3.4

216.3

800

2401

W85

ICPC

Gestational diabetes

2.6

215.4

1299

5125

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

215.0

8274

60228

O13

ICD-10 Finland

Gestational [pregnancy-induced] hypertension

2.6

214.6

1330

5317

H3600, E113,

ICD-10 Finland

6.4

213.6

354

557

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.6

213.4

6058

41051

N05CF01

ATC

zopiclone; oral

1.6

213.1

6960

48775

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.2

212.4

1831

8485

SPAT1255

SPAT

Intravenous administration of medicine

2.3

211.4

1653

7350

M01AE02

ATC

naproxen; oral, rectal

1.5

210.1

14044

114728

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.2

209.9

1868

8769

J01CE02

ATC

phenoxymethylpenicillin; oral

1.5

209.8

17155

146216

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.0

208.2

2524

13314

T07

ICPC

Weight gain

4.3

207.9

546

1291

B01AF01

ATC

rivaroxaban; oral

2.0

207.1

2588

13796

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

206.6

2794

15300

N03AX09

ATC

lamotrigine; oral

2.4

206.2

1476

6310

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.8

205.7

3668

21903

C08CA02

ATC

felodipine; oral

2.2

204.1

1835

8646

L16

ICPC

Ankle symptom/complaint

1.9

203.9

2861

15853

O10.0

ICD-10 Finland

Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium

4.1

203.9

569

1408

A06AD11

ATC

lactulose; oral

1.9

203.8

2784

15292

R06AE07

ATC

cetirizine; oral

1.5

203.5

10970

85524

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.9

203.1

606

1574

ZXD05

NOMESCO Finland

Urgent procedure

1.6

202.6

7255

51806

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.9

202.6

2870

15952

B01AB04

ATC

dalteparin; parenteral

2.5

202.6

1326

5439

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

5.9

202.0

368

636

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.1

201.1

1952

9479

M70.6

ICD-10 Finland

Trochanteric bursitis

1.9

201.1

2961

16661

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

200.7

6444

44859

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

3.1

198.4

846

2768

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

4.6

198.4

473

1036

QBJ05

NOMESCO Finland

Other correction of loose or redundant skin of trunk

44.8

196.4

116

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.4

194.6

1363

5767

Z3226

NOMESCO Finland

Physiotherapist

1.7

193.5

4074

25464

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

193.0

6413

44926

J20

ICD-10 Finland

Acute bronchitis

1.9

192.1

2575

14039

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.8

192.0

3240

19002

K04.08

ICD-10 Finland

Other specified pulpit

2.0

191.6

2143

10970

N02BF01

ATC

gabapentin; oral

2.1

191.3

2016

10096

C07AG02

ATC

carvedilol; oral

2.6

191.0

1201

4830

SPAT1153

SPAT

Removal of sutures

1.6

190.8

6876

49036

N05AA02

ATC

levomepromazine; systemic

2.7

187.6

1022

3826

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

187.1

1962

9803

N02BF02

ATC

pregabalin; oral

2.3

186.8

1531

6936

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.3

186.3

1503

6764

N18.8

ICD-10 Finland

Other chronic renal failure

3.7

185.6

590

1602

B01AB10

ATC

tinzaparin; parenteral

2.0

185.4

2361

12643

SPAT1283

SPAT

Restricted health certificate

1.6

185.4

5019

33443

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

184.7

12873

104841

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

184.2

3217

19043

C09DA03

ATC

valsartan and diuretics; oral

2.6

184.1

1095

4285

R05

ICPC

Cough

1.6

183.8

5734

39514

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

183.3

5707

39303

A10BX09

ATC

[U] dapagliflozin

6.1

182.9

318

525

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

6.1

182.4

320

533

UJF32

NOMESCO Finland

Coloscopy

1.6

180.8

5556

38129

C10AA07

ATC

rosuvastatin; oral

1.5

180.6

6666

47677

M02AA07

ATC

piroxicam; topical

1.5

180.5

7574

55682

R03AC03

ATC

terbutaline; inhalant

1.8

180.2

3349

20177

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

5.8

179.5

329

572

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

179.2

5937

41443

WX402

NOMESCO Finland

General anaesthesia

1.6

178.6

5139

34708

R01AD09

ATC

mometasone; nasal

1.5

178.0

11323

90367

A01

ICPC

Pain general/multiple sites

2.0

177.8

2124

11119

J01CF05

ATC

flucloxacillin; systemic

2.2

177.2

1559

7270

R73.0

ICD-10 Finland

Abnormal glucose tolerance test

3.4

177.0

657

1975

H3601, E113,

ICD-10 Finland

5.0

176.2

378

758

J01MA02

ATC

ciprofloxacin; systemic

1.5

175.8

8445

63755

AA40B, ,

NOMESCO Finland

9.2

175.7

212

231

J01CA04

ATC

amoxicillin; systemic

1.6

175.4

20381

183041

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.8

175.4

920

3376

LCA06

NOMESCO Finland

Biopsy of endometrium

1.8

174.9

2959

17332

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

174.4

1701

8261

H02AB07

ATC

prednisone; oral

1.8

174.2

3016

17786

R5110, ,

SPAT

2.3

174.1

1411

6358

R51.80

ICD-10 Finland

Headache

1.7

174.0

3983

25387

SPAT1097

SPAT

Recording of ECG

1.8

173.9

3006

17720

I50.1

ICD-10 Finland

Left ventricular failure

2.8

173.4

880

3173

K42.0

ICD-10 Finland

Umbilical hernia with obstruction, without gangrene

4.8

173.3

393

826

C01AA05

ATC

digoxin; systemic

2.5

173.2

1157

4785

F34.1

ICD-10 Finland

Dysthymia

2.6

172.5

1052

4166

R06.2

ICD-10 Finland

Wheezing

2.5

172.3

1165

4845

R53

ICD-10 Finland

Malaise and fatigue

1.6

172.1

5528

38260

WZA90

NOMESCO Finland

Other medical or dental certificate

1.6

171.2

5683

39621

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.8

170.0

2929

17239

Z71.8

ICD-10 Finland

Other specified counselling

1.5

169.6

7544

55975

S80.0

ICD-10 Finland

Contusion of knee

2.0

169.4

1917

9837

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.6

169.0

1008

3948

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

168.4

2269

12364

K08.3

ICD-10 Finland

Retained dental root

2.1

168.4

1736

8607

AN1

Coronary angiography

2.0

168.2

1936

9994

A12BA01

ATC

potassium chloride; oral

3.1

165.9

706

2306

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

165.3

2172

11734

SPAT1377

SPAT

Polysomnography

2.7

164.9

906

3404

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.9

164.6

806

2850

WX320

NOMESCO Finland

Spinalanesthesy

1.6

163.3

5284

36569

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.3

162.6

1296

5795

J01FA09

ATC

clarithromycin; systemic

1.5

162.0

7467

55686

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.0

161.5

1851

9537

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

161.3

1604

7841

R03BA01

ATC

beclometasone; inhalant

1.7

161.3

3192

19528

D07AC01

ATC

betamethasone; topical

1.5

161.0

8175

62123

R32

ICD-10 Finland

Unspecified urinary incontinence

3.2

160.9

665

2135

H02AB04

ATC

methylprednisolone; systemic

1.7

160.1

3251

20028

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

160.0

8919

68975

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.7

159.6

860

3199

D11

ICPC

Diarrhoea

1.7

159.4

3035

18363

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

158.6

3886

25145

SPAT1234

SPAT

Support of social functional capacity

2.5

158.1

1044

4292

R03DA04

ATC

theophylline; systemic, rectal

2.6

157.9

963

3812

R4110, ,

SPAT

2.0

157.7

1974

10484

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.8

157.3

2769

16377

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

156.8

2077

11242

L60.0

ICD-10 Finland

Ingrowing nail

2.3

156.1

1186

5193

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.3

153.5

1185

5224

XG410

NOMESCO Finland

Flow-volume spirometry

2.6

153.5

936

3704

RD112, ,

NOMESCO Finland

12.3

152.9

151

123

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.9

152.8

1954

10450

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.9

151.2

2247

12618

M01AX05

ATC

glucosamine; oral

1.7

150.9

3457

21964

SGC10

NOMESCO Finland

Pulp capping

1.8

150.7

2363

13492

N05CD07

ATC

temazepam; oral

1.9

150.2

2115

11674

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

4.8

149.6

340

716

A10AE06

ATC

insulin degludec; parenteral

2.6

149.4

909

3593

I48.2

ICD-10 Finland

Chronic atrial fibrillation

2.8

148.8

778

2848

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

148.3

7680

58357

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.3

146.6

1130

4978

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.6

146.5

498

1414

D64.9

ICD-10 Finland

Anaemia, unspecified

1.9

146.4

1956

10608

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.9

146.4

721

2556

M01AH01

ATC

celecoxib; oral

1.6

146.4

3793

24839

SPAT1094

SPAT

Continuous Positive Airway Pressure

4.6

146.2

352

777

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.2

145.2

1356

6464

K04.1

ICD-10 Finland

Necrosis of pulp

1.7

145.1

2704

16234

L30.4

ICD-10 Finland

Erythema intertrigo

4.1

144.8

400

982

S29

ICPC

Skin symptom/complaint other

1.6

144.5

4168

27992

F50.8

ICD-10 Finland

Other eating disorders

7.3

144.4

212

293

N05AX08

ATC

risperidone; systemic

2.0

144.3

1632

8357

R04

ICPC

Breathing problem other

2.5

144.2

942

3851

P99

ICPC

Psychological disorders other

2.6

144.2

843

3267

A02BC05

ATC

esomeprazole; systemic

1.4

144.0

9070

71349

N62

ICD-10 Finland

Hypertrophy of breast

2.3

143.9

1114

4916

Z3229

NOMESCO Finland

Other healthcare associate professional

2.0

143.7

1758

9253

A03

ICPC

Fever

1.6

143.7

4279

28950

SPAT1058

SPAT

PEF monitoring instruction

1.9

143.2

1842

9863

SPAT1281

SPAT

Other administrative function

1.9

143.1

1857

9972

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.7

142.8

767

2847

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.8

142.2

2277

13072

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

141.9

3311

21108

SPAT1104

SPAT

Monitoring of emergency patient

2.1

141.8

1442

7101

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.5

141.8

4846

33799

L73.2

ICD-10 Finland

Hidradenitis suppurativa

4.1

141.2

389

953

N05BA01

ATC

diazepam; systemic, rectal

1.7

140.9

2758

16779

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

140.4

3240

20590

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.9

140.4

1947

10683

C10AX09

ATC

ezetimibe; oral

1.7

139.8

3105

19538

TFP20

NOMESCO Finland

Cardiodefibrillation

2.1

139.5

1343

6475

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

139.0

5411

38770

M54

ICD-10 Finland

Dorsalgia

1.7

138.7

3039

19052

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

4.3

138.1

360

846

E0000UV, ,

ATC

1.4

137.6

9669

77347

P29

ICPC

Psychological sympt/compl other

1.9

137.2

1863

10151

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.2

137.2

1221

5708

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

137.1

2301

13390

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.6

136.9

827

3256

L14

ICPC

Leg/thigh symptom/complaint

1.9

136.8

1746

9320

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.8

136.4

2413

14259

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

3.8

135.6

417

1106

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.1

135.5

580

1900

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

2.8

135.3

694

2514

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

135.2

5028

35655

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.6

134.4

819

3238

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

134.1

3428

22330

A02BC03

ATC

lansoprazole; oral

1.5

134.0

5930

43549

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.2

133.7

1249

5951

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.1

133.5

1371

6773

XA420

NOMESCO Finland

Extensive sleep examination

4.4

133.0

339

783

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

132.9

6340

47227

M01AX17

ATC

nimesulide; oral

1.5

132.6

4743

33344

WX002

NOMESCO Finland

Sedation and analgesia

1.6

132.5

3935

26551

R03AK08

ATC

formoterol and beclometasone; inhalant

2.3

131.9

1083

4897

J45.8

ICD-10 Finland

Mixed asthma

2.6

131.8

762

2935

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

131.7

16625

146202

N19

ICD-10 Finland

Unspecified kidney failure

2.9

131.6

650

2307

M01AB01

ATC

indometacin; systemic, rectal

2.1

131.5

1363

6755

AA1AD

NOMESCO Finland

CT of head and brain

1.5

131.5

5191

37241

JAF30

NOMESCO Finland

Repair of umbilical hernia using prosthetic material

3.0

131.2

588

1978

F61.0

ICD-10 Finland

Mixed personality disorders

3.2

130.5

531

1688

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.2

130.4

518

1623

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.5

129.7

862

3551

R74

ICPC

Upper respiratory infection acute

1.4

129.4

8171

63978

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

129.3

4014

27344

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.7

129.0

691

2561

SPAT1054

SPAT

Examination of peripheral nervous system

3.6

128.9

433

1220

XF402

NOMESCO Finland

ECG with work load test

1.8

128.3

2047

11722

A10BD20

ATC

metformin and empagliflozin; oral

3.9

128.2

382

991

D01AC02

ATC

miconazole; topical

2.0

128.0

1559

8184

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

128.0

2153

12526

N06AX03

ATC

mianserin; oral

2.3

127.4

1059

4812

JJA21

NOMESCO Finland

Laparoscopic biopsy of liver

11.7

127.1

130

112

J01DA09

ATC

[U] cefadroxil

1.5

126.8

6057

45056

L86

ICPC

Back syndrome with radiating pain

2.0

126.8

1396

7072

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.5

126.6

840

3457

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

126.5

2935

18642

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

126.2

5336

38762

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

126.0

6120

45659

C03BA11

ATC

indapamide; oral

3.0

125.4

579

1980

4019X

ICD-9 Finland

Essential hypertension, Unspecified

3.6

125.2

424

1201

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.8

125.2

1948

11069

L08

ICPC

Shoulder symptom/complaint

1.5

125.0

4680

33161

SPAT1059

SPAT

Spirometry at the office

2.2

124.9

1120

5248

A10BX02

ATC

repaglinide; oral

4.4

124.6

314

719

C10AB05

ATC

fenofibrate; oral

3.4

124.3

456

1360

N06AX26

ATC

vortioxetine; oral

1.8

124.0

1843

10323

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.8

123.9

646

2360

G04BD12

ATC

mirabegron; oral

1.8

123.3

2193

12960

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.8

122.9

1836

10299

F32.1

ICD-10 Finland

Moderate depressive episode

1.9

122.6

1614

8694

N05AF03

ATC

chlorprothixene; systemic

2.7

122.4

677

2550

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

3.3

122.3

471

1448

KGH10

NOMESCO Finland

Operation for phimosis

3.0

122.0

565

1936

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.3

121.9

941

4143

H01

ICPC

Ear pain/earache

1.6

121.9

2819

17879

A41.9

ICD-10 Finland

Sepsis, unspecified

2.6

121.8

713

2763

R42

ICD-10 Finland

Dizziness and giddiness

1.5

121.2

4604

32695

D07AC13

ATC

mometasone; topical

1.4

120.9

6404

48480

A04

ICPC

Weakness/tiredness general

1.6

120.5

3183

20854

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.9

120.2

597

2125

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.6

120.0

2806

17842

K77

ICPC

Heart failure

3.7

119.5

381

1036

R11

ICD-10 Finland

Nausea and vomiting

1.8

119.3

1916

10985

F32

ICD-10 Finland

Depressive episode

2.0

119.0

1443

7558

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

118.9

8291

65775

R03AC13

ATC

formoterol; inhalant

2.2

118.6

1079

5083

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

118.5

2739

17363

A10AB06

ATC

insulin glulisine; parenteral

4.4

118.2

303

703

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.8

116.3

1852

10588

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

116.2

9838

80448

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

116.1

1553

8405

R03AC12

ATC

salmeterol; inhalant

2.3

115.9

904

3997

K78

ICPC

Atrial fibrillation/flutter

2.0

115.7

1236

6189

WX725

NOMESCO Finland

Noninvasive ventilation

2.0

115.3

1259

6355

SPAT1051

SPAT

Guidance regarding sleep disorders

3.2

115.2

456

1426

R50.9

ICD-10 Finland

Fever, unspecified

1.6

113.9

3219

21407

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

113.8

1951

11396

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.3

113.8

885

3908

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

113.7

2168

13053

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.3

113.5

437

1343

C09CA07

ATC

telmisartan; oral

1.9

113.4

1489

8009

J01FA10

ATC

azithromycin; systemic

1.4

113.1

14004

121181

O24.9

ICD-10 Finland

Diabetes mellitus in pregnancy, unspecified

2.8

112.8

568

2037

N05AN01

ATC

lithium; oral

2.7

112.5

640

2445

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

111.8

4151

29285

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.3

111.7

887

3951

EBA30

NOMESCO Finland

Extraction of root of tooth

2.1

111.4

1168

5807

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.5

111.2

697

2792

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.1

111.1

1140

5623

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.6

110.9

2564

16235

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.2

110.6

963

4456

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.2

110.6

960

4437

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.3

110.6

864

3823

R99

ICPC

Respiratory disease other

3.1

110.5

469

1529

R4110

NOMESCO Finland

Physiotherapy

1.4

110.3

5707

42892

M01AC06

ATC

meloxicam; systemic, rectal

1.4

110.2

7668

60627

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

110.0

2595

16515

C09DA07

ATC

telmisartan and diuretics; oral

2.3

109.5

879

3934

MAC40

NOMESCO Finland

Pharmacological induction or advancement of labor

2.8

109.4

572

2093

C08DB01

ATC

diltiazem; oral

2.4

109.2

773

3276

U04

ICPC

Incontinence urine

2.2

109.1

986

4632

XF600

NOMESCO Finland

Bloodpressure measurement

2.0

108.8

1299

6763

SPAT1307

SPAT

Psychosocial counselling and guidance

1.8

108.8

1638

9200

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.3

108.7

407

1230

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.9

108.4

1510

8276

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.0

108.2

1197

6067

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.2

108.2

990

4673

T92

ICPC

Gout

3.3

107.3

418

1294

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.1

107.2

1062

5168

M79.1

ICD-10 Finland

Myalgia

1.5

107.0

3351

22778

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.8

107.0

1832

10692

K04.09

ICD-10 Finland

Pulpit UNS

2.0

107.0

1158

5824

A08AA01

ATC

phentermine; oral

7.6

106.9

151

200

M02AA10

ATC

ketoprofen; topical

1.6

106.8

3236

21835

L13

ICPC

Hip symptom/complaint

1.5

106.6

3547

24430

J01MA14

ATC

moxifloxacin; systemic

1.8

106.4

1847

10820

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.1

106.2

1034

4998

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.3

106.2

804

3509

I48.1

ICD-10 Finland

Persistent atrial fibrillation

2.5

106.1

690

2812

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

3.0

106.0

466

1550

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.7

105.9

571

2122

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.6

105.7

611

2353

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.5

105.6

673

2717

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.7

105.6

565

2092

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.8

105.2

529

1896

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.9

105.0

492

1697

Z01.2

ICD-10 Finland

Dental examination

1.3

104.9

10895

91417

EB1VA, ,

NOMESCO Finland

1.6

104.8

2911

19252

B01AC04

ATC

clopidogrel; oral

1.6

104.7

2617

16880

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

104.3

6433

49763

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.9

104.2

1438

7855

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.8

104.2

1732

10018

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.9

104.1

1282

6744

K10.3

ICD-10 Finland

Alveolitis of jaws

2.0

103.9

1218

6299

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.8

103.7

525

1888

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

103.5

2264

14121

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.8

103.5

543

1990

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

103.2

4404

31879

C07BB07

ATC

bisoprolol and thiazides; systemic

2.4

103.2

755

3246

O80.8

ICD-10 Finland

Other single spontaneous delivery

2.0

103.2

1160

5912

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

103.2

6727

52497

R01AD08

ATC

fluticasone; nasal

1.4

102.0

6621

51615

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.1

101.9

423

1361

A10AB04

ATC

insulin lispro; parenteral

2.3

101.6

766

3337

CK2S4, ,

SPAT

3.5

101.4

350

1004

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.5

101.4

656

2667

SPAT1252

SPAT

Overall medication plan or its review

1.9

101.4

1245

6543

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

101.3

2049

12519

CL2S4, ,

SPAT

3.4

101.1

371

1107

L68.0

ICD-10 Finland

Hirsutism

4.6

100.9

239

521

N06AX05

ATC

trazodone; oral

2.5

100.8

647

2620

K05.31

ICD-10 Finland

Periodontitis pronounced

1.7

100.8

2156

13366

A02BA02

ATC

ranitidine; systemic

1.5

100.6

3584

25011

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.7

100.6

2083

12803

N03AG01

ATC

valproic acid; systemic, rectal

1.9

100.6

1338

7221

E000001, ,

ATC

1.5

100.5

4420

32162

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.1

100.4

952

4554

D07XC01

ATC

betamethasone; topical

1.6

100.3

2458

15771

D07AD01

ATC

clobetasol; topical

1.5

99.8

3543

24706

M01AH02

ATC

rofecoxib; oral

1.6

99.7

2352

14946

JDF97

NOMESCO Finland

Other laparoscopic bariatric operation on stomach

+∞

99.0

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.9

98.8

1386

7607

M09AX01

ATC

hyaluronic acid; parenteral

2.2

98.6

818

3710

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

2.8

98.4

506

1835

R29

ICPC

Respiratory symptom/complaint other

1.8

98.2

1513

8551

A08AX01

ATC

rimonabant; oral

23.0

98.0

ZYC01

NOMESCO Finland

Remote contact by phone

1.9

97.9

1358

7426

ZY010

NOMESCO Finland

Hospital outpatient

1.9

97.9

1237

6562

SGB20

NOMESCO Finland

Root filling of tooth with onetwo root canals

1.8

97.6

1521

8626

C02EA02, ,

ATC

2.5

97.4

623

2519

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.2

96.8

837

3861

J96.0

ICD-10 Finland

Acute respiratory failure

4.2

96.7

261

630

D07BC01

ATC

betamethasone and antiseptics; topical

1.6

96.7

2491

16167

TQW80

NOMESCO Finland

Local dermatologic skincare

2.5

96.5

613

2471

212

Kela drug reimbursment

Gout

3.4

96.4

352

1047

F50.3

ICD-10 Finland

Atypical bulimia nervosa

5.1

96.2

202

398

OAB50

NOMESCO Finland

Delivery of care equipment and instruction on their use

4.9

96.0

214

444

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.3

95.8

758

3370

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

95.8

5677

43507

O82.10

ICD-10 Finland

Delivery by emergency caesarean section

1.8

95.8

1396

7754

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.0

95.4

441

1509

R52.9

ICD-10 Finland

Pain, unspecified

1.6

95.4

2142

13439

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.6

95.3

2490

16211

R4180, ,

SPAT

4.3

95.2

248

583

G44.2

ICD-10 Finland

Tension-type headache

1.5

95.1

3186

21927

A99

ICPC

Disease/condition unspecnature/site

1.7

95.1

1898

11547

P01

ICPC

Feeling anxious/nervous/tense

1.5

95.0

3079

21041

RK320, ,

NOMESCO Finland

4.8

94.9

215

452

NG2AA

NOMESCO Finland

Patella X-ray examination

2.5

94.6

601

2422

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.8

94.6

1620

9444

K86

ICPC

Hypertension uncomplicated

1.6

94.5

2178

13753

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

2.5

94.2

619

2534

SGA04

NOMESCO Finland

Opening and preparing the root canals, extremely complicated

1.6

94.1

2629

17384

WVA30, ,

SPAT

2.0

94.0

1122

5836

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

1.9

93.8

1249

6740

UKC02

NOMESCO Finland

Cystoscopy

1.6

93.3

2735

18281

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

2.1

93.2

877

4182

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.2

93.1

859

4066

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

3.7

93.0

294

795

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

93.0

1372

7648

N05BA12

ATC

alprazolam; oral

1.6

92.8

2095

13155

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

4.2

92.8

247

590

RD160, ,

NOMESCO Finland

10.0

92.8

105

B02AA02

ATC

tranexamic acid; systemic

1.5

92.7

3423

24028

N02AJ13

ATC

tramadol and paracetamol; systemic

2.6

92.7

532

2041

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.1

92.5

400

1318

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.7

92.2

492

1819

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.0

91.7

1004

5066

N06AA12

ATC

doxepin; systemic

2.0

91.3

988

4965

N03AX11

ATC

topiramate; oral

2.4

91.2

667

2866

I20.09

ICD-10 Finland

Unstable angina

2.1

90.8

914

4471

TK800

NOMESCO Finland

Hemodialysis

2.8

90.5

470

1713

J02AC01

ATC

fluconazole; systemic

1.3

90.4

9421

78522

N05AB03

ATC

perphenazine; systemic, rectal

2.2

90.4

764

3491

JAH01

NOMESCO Finland

Laparoscopy

2.0

90.2

1078

5608

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

4.0

90.1

259

655

A10BD15

ATC

metformin and dapagliflozin; oral

4.2

90.1

241

578

A08AA04

ATC

dexfenfluramine; oral

10.5

90.0

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.2

89.1

786

3654

WZC00, ,

SPAT

1.6

88.8

2213

14233

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

5.3

88.7

178

337

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

88.6

3160

22007

N04BC05

ATC

pramipexole; oral

1.8

88.5

1429

8185

M15

ICD-10 Finland

Polyarthrosis

2.1

88.3

924

4586

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.6

88.3

503

1923

N05AH03

ATC

olanzapine; systemic

1.8

88.1

1387

7883

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.3

87.8

706

3160

C09AA03

ATC

lisinopril; oral

2.2

87.8

806

3807

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.9

87.7

1234

6776

MAC10

NOMESCO Finland

Antepartum dilatation of cervical canal

2.4

87.2

629

2686

N06AB05

ATC

paroxetine; oral

1.8

87.1

1369

7777

N30.0

ICD-10 Finland

Acute cystitis

1.5

87.1

3446

24498

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.7

87.0

487

1845

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

3.7

86.8

275

745

OAB42, ,

SPAT

1.6

86.8

2244

14556

Z2446

NOMESCO Finland

Social worker

1.8

86.8

1363

7741

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

4.2

86.5

229

545

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.0

86.4

1037

5403

K73.80

ICD-10 Finland

Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)

6.2

86.3

146

235

UJD02

NOMESCO Finland

Gastroscopy

2.0

85.9

916

4578

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

85.8

6122

48190

K85

ICPC

Elevated blood pressure

1.5

85.8

2796

19103

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.3

85.5

639

2772

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.0

85.5

977

5004

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.6

85.4

2197

14231

C09BA03

ATC

lisinopril and diuretics; oral

2.8

85.4

443

1614

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

5.0

85.2

182

364

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.6

85.1

2257

14724

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.9

85.0

1099

5871

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.1

84.9

804

3842

O61.0

ICD-10 Finland

Failed medical induction of labour

3.4

84.9

313

937

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.1

84.6

800

3821

H66.9

ICD-10 Finland

Otitis media, unspecified

1.7

84.6

1509

8892

JDF21

NOMESCO Finland

Laparoscopic gastric banding

+∞

84.4

MCA10

NOMESCO Finland

Lower uterine segment caesarean section

1.6

84.3

2358

15571

SPAT1257

SPAT

Teaching of medicine inhalation technique

2.3

84.2

689

3106

ZXA00

NOMESCO Finland

Right side

1.4

84.0

4879

37140

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

83.9

1336

7616

F50.4

ICD-10 Finland

Overeating associated with other psychological disturbances

18.9

83.9

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.1

83.9

864

4262

WZC30, ,

SPAT

1.9

83.5

1146

6240

H36.01

ICD-10 Finland

Diabetic maculopathy

3.3

83.4

316

962

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

3.1

83.2

361

1192

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.2

83.0

709

3253

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.4

83.0

5287

40847

M76.6

ICD-10 Finland

Achilles tendinitis

1.9

82.9

1085

5819

G93.2

ICD-10 Finland

Benign intracranial hypertension

8.0

82.8

112

141

J96.9

ICD-10 Finland

Respiratory failure, unspecified

5.2

82.4

170

330

S20

ICPC

Corn/callosity

2.8

82.4

411

1467

C08CA10

ATC

nilvadipine; oral

3.0

82.3

372

1258

Z50.1

ICD-10 Finland

Other physical therapy

1.9

82.0

1051

5597

I25.2

ICD-10 Finland

Old myocardial infarction

2.0

81.9

904

4573

G04BD08

ATC

solifenacin; oral

1.9

81.9

1151

6315

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

81.8

4372

32798

RD130, ,

NOMESCO Finland

36.5

81.8

ZXA05

NOMESCO Finland

Left side

1.4

81.8

4521

34113

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.6

81.7

1961

12488

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

81.6

2788

19223

SPAT1251

SPAT

Organisation of medication

2.3

81.5

662

2975

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.6

81.4

2220

14572

A10BB07

ATC

glipizide; oral

4.7

81.3

190

410

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.7

81.3

449

1690

SPAT1325

SPAT

Vaccination

1.3

81.2

6454

51557

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

80.9

1449

8545

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

80.7

675

3070

N97.0

ICD-10 Finland

Female infertility associated with anovulation

2.4

80.7

546

2266

G04BD04

ATC

oxybutynin; oral, transdermal

2.0

80.2

898

4565

D05AX52

ATC

calcipotriol, combinations; topical

1.8

79.9

1147

6334

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.6

79.9

1944

12419

E87.6

ICD-10 Finland

Hypokalaemia

2.3

79.7

646

2901

QDB10, ,

SPAT

3.0

79.7

364

1238

NF1AA

NOMESCO Finland

Hip X-ray examination

1.7

79.7

1485

8854

R21

ICPC

Throat symptom/complaint

1.4

79.7

5149

39832

SPAT1360

SPAT

Extensive global examination

1.8

79.6

1366

7957

JAF11

NOMESCO Finland

Laparoscopic repair of umbilical hernia

4.3

79.5

203

470

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.1

79.5

749

3573

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

79.2

1983

12754

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.5

79.1

517

2112

R01AD12

ATC

fluticasone furoate; nasal

1.3

78.9

7501

61409

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.8

78.9

389

1380

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.5

78.8

524

2157

A10BD08

ATC

metformin and vildagliptin; systemic

4.3

78.8

206

486

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

2.7

78.7

420

1553

K80.8

ICD-10 Finland

Other cholelithiasis

2.8

78.7

398

1431

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

78.6

6433

51555

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.8

78.6

1294

7448

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.5

78.4

505

2049

D10

ICPC

Vomiting

1.7

78.4

1478

8840

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

78.1

2500

16991

C09DX01

ATC

valsartan, amlodipine and hydrochlorothiazide; oral

2.7

78.1

434

1639

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.7

77.8

1597

9771

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.1

77.7

338

1118

Z08

ICPC

Social welfare problem

3.1

77.5

336

1109

C10AB02

ATC

bezafibrate; oral

3.8

77.1

233

611

XQ800

NOMESCO Finland

Prick test

1.6

77.1

1731

10836

N01

ICPC

Headache

1.5

77.1

2585

17741

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.4

76.9

280

832

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

76.8

1213

6896

S01

ICPC

Pain/tenderness of skin

1.9

76.7

947

4979

L29

ICPC

Musculoskeletal sympt/complt other

1.6

76.3

1739

10927

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.4

76.3

544

2312

SPAT1151

SPAT

Treatment of major wounds

3.5

76.3

265

764

E87.5

ICD-10 Finland

Hyperkalaemia

3.1

76.3

315

1011

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.7

76.2

405

1495

H25.8

ICD-10 Finland

Other senile cataract

1.7

76.1

1506

9123

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.7

76.1

422

1592

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

2.3

76.0

566

2451

C10AA04

ATC

fluvastatin; oral

1.8

75.9

1308

7626

S21

ICPC

Skin texture symptom/complaint

1.5

75.8

2802

19614

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.7

75.7

426

1619

A29

ICPC

General symptom/complaint other

1.5

75.5

2367

16010

X58

ICD-10 Finland

Exposure to other specified factors

1.5

75.4

3008

21367

K04.00

ICD-10 Finland

Hyperemia of pulp

1.8

75.4

1100

6103

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

8.1

74.9

100

124

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.7

74.8

1585

9774

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.6

74.8

249

698

SPAT1202

SPAT

Intra-articular injection

2.3

74.8

578

2544

SGB30

NOMESCO Finland

Other complicated root filling

1.5

74.7

2723

19000

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

74.5

1095

6089

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

2.2

74.2

609

2749

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.2

74.0

296

932

N05CF02

ATC

zolpidem; oral

1.4

74.0

3691

27308

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

5.2

74.0

152

294

I11

ICD-10 Finland

Hypertensive heart disease

5.7

74.0

137

241

RD140, ,

NOMESCO Finland

91.5

73.9

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.0

73.9

823

4176

LCA13

NOMESCO Finland

Curettage of cervix and body of uterus

1.9

73.8

1044

5738

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.7

73.7

1546

9510

ZXA10

NOMESCO Finland

Bilateral

1.4

73.6

3429

25061

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.4

73.5

496

2056

-1, ,

NOMESCO Finland

1.3

73.5

7561

62428

D07AA02

ATC

hydrocortisone; topical

1.5

73.4

3004

21437

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.0

73.3

802

4043

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.0

73.2

817

4148

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.8

73.1

1233

7143

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

3.2

73.1

291

914

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

3.4

73.0

270

810

XA421

NOMESCO Finland

Nocturnal polygraphy

4.6

73.0

171

370

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.9

72.9

1030

5657

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.7

72.9

396

1478

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.0

72.8

804

4066

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

3.3

72.8

277

846

D07CC01

ATC

betamethasone and antibiotics; topical

1.5

72.8

2541

17571

K92.1

ICD-10 Finland

Melaena

1.9

72.7

900

4736

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.8

72.6

369

1330

N06AG02

ATC

moclobemide; oral

2.0

72.5

873

4551

S22

ICPC

Nail symptom/complaint

1.7

72.4

1258

7351

E68

ICD-10 Finland

Sequelae of hyperalimentation

20.4

72.3

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.8

72.2

1058

5877

L12

ICPC

Hand/finger symptom/complaint

1.4

72.2

3411

24987

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

2.8

72.2

368

1329

R52.2

ICD-10 Finland

Other chronic pain

2.0

72.1

779

3910

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

2.5

71.6

453

1822

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.0

71.6

854

4437

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.8

71.4

1147

6552

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

71.3

3640

27024

Z00.0

ICD-10 Finland

General medical examination

1.4

71.2

3932

29579

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.2

70.9

596

2716

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

70.7

773

3895

NHQ40

NOMESCO Finland

Amputation of toe

3.1

70.7

291

932

G57.1

ICD-10 Finland

Meralgia paraesthetica

2.8

70.6

367

1339

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

70.2

2132

14311

E000003, ,

ATC

1.9

70.2

927

4983

D09AB01

ATC

zinc bandage without supplements; topical

2.6

70.1

407

1571

C10AA03

ATC

pravastatin; oral

1.8

70.1

1127

6439

C09DB01

ATC

valsartan and amlodipine; oral

2.1

69.9

640

3018

H3603, E113,

ICD-10 Finland

4.1

69.9

190

462

SFC92

NOMESCO Finland

Other complicated additional procedure necessary for restorative treatment

1.7

69.8

1316

7864

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

69.8

2024

13450

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

69.7

2060

13744

R01AD58

ATC

fluticasone, combinations; nasal

1.3

69.7

5766

46134

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.3

69.6

557

2488

SFD11

NOMESCO Finland

Gradual caries removal, at least two tooth surfaces

2.3

69.5

538

2369

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.2

69.5

614

2856

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

2.6

69.4

398

1527

R03BA08

ATC

ciclesonide; inhalant

1.6

69.3

1848

12048

L01

ICPC

Neck symptom/complaint

1.4

69.1

3354

24671

SPAT1285

SPAT

Provision of consultation response

1.8

69.0

1041

5835

R04.0

ICD-10 Finland

Epistaxis

1.7

68.8

1256

7440

WX111

NOMESCO Finland

Local infiltration anesthesia

2.1

68.7

631

2979

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.0

68.7

308

1037

WX704

NOMESCO Finland

Intubation

1.6

68.7

1683

10755

S06

ICPC

Rash localized

1.8

68.6

1104

6307

J01DA06

ATC

[U] cefuroxime

1.4

68.6

2920

20973

E65

ICD-10 Finland

Localized adiposity

8.5

68.5

104

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

68.5

1262

7494

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.0

68.4

715

3546

E78.11

ICD-10 Finland

Other hypertriglyceridemia

4.5

68.3

166

370

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

2.2

68.2

590

2721

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.0

68.0

718

3573

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.5

68.0

2065

13858

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

4.4

67.9

169

384

N05BA06

ATC

lorazepam; systemic, sublingual

1.9

67.9

913

4936

A11CC03

ATC

alfacalcidol; systemic

2.4

67.9

459

1905

T29

ICPC

Endocr/metab/nutr sympt/compl other

2.6

67.8

407

1597

K04.7

ICD-10 Finland

Periapical abscess without sinus

1.7

67.7

1216

7170

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

67.6

2057

13811

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

2.1

67.5

647

3106

R05

ICD-10 Finland

Cough

1.4

67.5

4374

33731

SPAT1172

SPAT

Guidance concerning hydration

2.7

67.3

363

1350

Z72.0

ICD-10 Finland

Tobacco use

2.2

67.2

585

2704

R07.3

ICD-10 Finland

Other chest pain

1.5

67.1

1954

12992

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

2.6

67.0

390

1507

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.3

67.0

505

2199

C07AB05

ATC

betaxolol; oral

2.5

66.9

413

1643

N18

ICD-10 Finland

Chronic kidney disease

4.0

66.9

192

486

N85.0

ICD-10 Finland

Endometrial glandular hyperplasia

2.6

66.8

383

1469

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.7

66.6

356

1318

R60.1

ICD-10 Finland

Generalized oedema

4.0

66.6

191

483

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.2

66.2

562

2572

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.0

66.1

699

3480

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.1

66.1

610

2886

P74

ICPC

Anxiety disorder/anxiety state

1.8

66.1

1020

5755

C07AB08

ATC

celiprolol; oral

2.5

65.9

407

1619

C07AB03

ATC

atenolol; systemic

1.9

65.6

842

4483

N05BE01

ATC

buspirone; oral

2.1

65.6

623

2981

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.0

65.5

786

4092

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.0

65.5

694

3459

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.8

65.4

1070

6141

G04BD07

ATC

tolterodine; oral

2.0

65.4

763

3933

AA43B, ,

NOMESCO Finland

26.5

65.4

J01FA01

ATC

erythromycin; systemic

1.4

65.3

3099

22685

N05AE04

ATC

ziprasidone; systemic

3.8

65.3

200

530

K03.66

ICD-10 Finland

Tooth plaque

1.6

64.9

1479

9281

XF640, ,

NOMESCO Finland

2.4

64.9

470

2012

D06AX01

ATC

fusidic acid; topical

1.5

64.8

1918

12795

G43.9

ICD-10 Finland

Migraine, unspecified

1.6

64.7

1479

9288

OAB74, ,

SPAT

3.7

64.7

208

570

S02CA02

ATC

flumetasone and antiinfectives; otic

1.8

64.6

1025

5830

IHZ05, ,

SPAT

1.9

64.3

887

4833

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

64.2

2668

19060

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.8

63.6

913

5038

R4180

NOMESCO Finland

Podiatric therapy

3.1

63.5

274

903

WX892

NOMESCO Finland

Monitored bed care

1.7

63.4

1366

8452

-50

ICPC

Medication/prescr/renewal

1.9

63.3

763

3977

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.5

63.3

397

1591

ULC02

NOMESCO Finland

Hysteroscopy

1.8

63.0

1049

6051

D02AE01

ATC

carbamide; topical

1.7

63.0

1312

8046

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

2.2

62.8

537

2465

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

1.8

62.7

950

5329

K80.1

ICD-10 Finland

Calculus of gallbladder with other cholecystitis

2.4

62.7

451

1925

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

0.5

62.4

770

13972

C08CA05

ATC

nifedipine; systemic

1.8

62.2

1024

5887

R05DA01

ATC

ethylmorphine; oral

1.6

62.1

1501

9554

J01FA15

ATC

telithromycin; oral

1.5

61.8

2035

13879

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

4.0

61.8

173

430

A05

ICPC

Feeling ill

1.7

61.8

1325

8187

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.6

61.7

1442

9105

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.1

61.7

637

3145

N07BB01

ATC

disulfiram; oral

1.8

61.6

884

4877

C07FB02

ATC

metoprolol and felodipine; systemic

2.3

61.6

458

1983

D01AC03

ATC

econazole; topical

1.7

61.5

1067

6227

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.8

61.4

908

5056

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.4

61.4

422

1765

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

61.3

8874

75985

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.7

61.1

344

1308

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

2.0

61.0

686

3491

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.1

61.0

584

2803

R09

ICPC

Sinus symptom/complaint

1.5

60.9

1866

12535

R78

ICPC

Acute bronchitis/bronchiolitis

2.3

60.9

453

1962

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

60.9

2051

14055

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.1

60.8

615

3012

R52.0

ICD-10 Finland

Acute pain

2.0

60.8

722

3745

M01AC01

ATC

piroxicam; systemic, rectal

1.5

60.7

2350

16553

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.0

60.7

661

3326

O26.0

ICD-10 Finland

Excessive weight gain in pregnancy

8.8

60.7

F32.8

ICD-10 Finland

Other depressive episodes

2.5

60.6

393

1600

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.8

60.6

1000

5753

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

60.5

539

2515

R03AK11

ATC

formoterol and fluticasone; inhalant

2.2

60.5

527

2438

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.8

60.3

951

5399

L02

ICPC

Back symptom/complaint

1.5

60.3

2147

14879

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.5

60.2

2121

14666

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

2.8

60.1

301

1078

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.0

59.9

704

3639

D82

ICPC

Teeth/gum disease

1.3

59.9

8484

72410

63703

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Prae-eclampsia levis

2.9

59.8

290

1020

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.6

59.8

1308

8121

SPAT1284

SPAT

Extensive health certificate

2.1

59.6

609

2994

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.7

59.5

1190

7219

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

59.5

22095

211032

ZXE00

NOMESCO Finland

One hour or less

1.3

59.5

8190

69653

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.0

59.3

623

3095

D91

ICPC

Abdominal hernia other

3.0

59.1

261

872

H70

ICPC

Otitis externa

2.3

59.0

476

2134

D07AB08

ATC

desonide; topical

1.5

58.7

2182

15247

F33.8

ICD-10 Finland

Other recurrent depressive disorders

3.1

58.6

250

819

D01

ICPC

Abdominal pain/cramps general

1.4

58.5

2507

17992

C09AA04

ATC

perindopril; oral

1.9

58.5

824

4519

K28

ICPC

Limited function/disability (K)

2.6

58.5

348

1360

Z71.9

ICD-10 Finland

Counselling, unspecified

1.6

58.5

1456

9330

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.1

58.4

584

2849

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

2.1

58.4

589

2883

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

1.9

58.4

706

3685

F29

ICD-10 Finland

Unspecified nonorganic psychosis

1.9

58.3

761

4073

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.7

58.2

1036

6090

QXB99, ,

SPAT

2.4

58.0

401

1682

N91.1

ICD-10 Finland

Secondary amenorrhoea

2.3

57.9

464

2074

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.7

57.8

1141

6898

M43.1

ICD-10 Finland

Spondylolisthesis

1.9

57.7

775

4186

R75

ICPC

Sinusitis acute/chronic

1.7

57.7

1067

6338

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

4.2

57.7

155

374

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

57.6

2953

21872

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.0

57.6

597

2952

SPAT1243

SPAT

Psychiatric/psychological examination

2.0

57.5

643

3266

D01AE15

ATC

terbinafine; topical

1.6

57.5

1243

7694

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.6

57.4

1338

8438

ECB00

NOMESCO Finland

Suture of gingiva

1.9

57.4

723

3826

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

3.6

57.3

190

532

Z13.5

ICD-10 Finland

Special screening examination for eye and ear disorders

3.4

57.1

206

609

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.3

56.9

438

1925

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

3.8

56.9

176

470

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.9

56.9

703

3696

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.4

56.9

2538

18346

L11

ICPC

Wrist symptom/complaint

1.5

56.8

1859

12656

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.6

56.8

1229

7610

SPAT1359

SPAT

Use of symptom diary

2.2

56.8

515

2421

NG1DA

NOMESCO Finland

X-ray of knees

2.5

56.7

353

1410

D05AX02

ATC

calcipotriol; topical

1.9

56.7

702

3693

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.7

56.6

988

5776

M01AB55

ATC

diclofenac, combinations; oral

1.7

56.5

1099

6617

O34.2

ICD-10 Finland

Maternal care due to uterine scar from previous surgery

1.6

56.5

1248

7767

XF404

NOMESCO Finland

Ambulatory ECG

1.6

56.5

1508

9821

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

2.8

56.5

277

981

N17

ICPC

Vertigo/dizziness

1.5

56.4

2168

15239

104

Kela drug reimbursment

Thyroid insufficiency

1.6

56.4

1291

8106

N06AA04

ATC

clomipramine; systemic

2.5

56.3

351

1403

IGY02, ,

SPAT

2.7

56.3

300

1110

GD2SN

NOMESCO Finland

Lung ventilation SPECT

4.1

56.2

154

377

N06AX22

ATC

agomelatine; oral

2.1

56.1

547

2643

L03.3

ICD-10 Finland

Cellulitis of trunk

3.4

56.1

200

587

A12AA04

ATC

calcium carbonate; oral

2.7

56.1

302

1123

S17

ICPC

Abrasion/scratch/blister

2.3

56.0

445

1982

N17.8

ICD-10 Finland

Other acute renal failure

3.1

56.0

231

742

D73

ICPC

Gastroenteritis presumed infection

1.8

55.9

804

4438

Z2445

NOMESCO Finland

Psychologist

1.8

55.9

860

4847

F41.09

ICD-10 Finland

UNS Panic Syndrome

1.9

55.8

687

3607

WVA20, ,

SPAT

2.1

55.8

514

2431

WZA00

NOMESCO Finland

Concise certificate

1.6

55.5

1351

8609

B80

ICPC

Iron deficiency anaemia

2.1

55.3

508

2399

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.7

55.3

1009

5970

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.6

55.3

335

1321

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.0

55.0

610

3089

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.4

55.0

373

1551

C01BD01

ATC

amiodarone; systemic

2.2

55.0

451

2036

ZX120

NOMESCO Finland

Intravenous

1.5

54.9

1736

11731

E03

ICD-10 Finland

Other hypothyroidism

1.6

54.7

1199

7445

L84

ICD-10 Finland

Corns and callosities

2.0

54.7

649

3365

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

54.7

3029

22707

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

54.7

1089

6598

Z00.8

ICD-10 Finland

Other general examinations

1.5

54.6

1580

10476

UJF92

NOMESCO Finland

Capsular endoscopy

2.2

54.6

462

2113

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

54.5

1322

8415

WX872

NOMESCO Finland

Intensive care

1.8

54.3

879

5028

R28

ICPC

Limited function/disability (R)

2.9

54.1

251

862

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.9

54.1

655

3419

N48.1

ICD-10 Finland

Balanoposthitis

2.2

54.0

441

1988

F31

ICD-10 Finland

Bipolar affective disorder

2.6

53.9

314

1215

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

53.8

1127

6917

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.7

53.8

987

5848

K91.1

ICD-10 Finland

Postgastric surgery syndromes

10.8

53.8

SPAT1238

SPAT

Brief therapy

2.2

53.8

452

2061

E86

ICD-10 Finland

Volume depletion

2.4

53.7

373

1568

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.3

53.5

3902

30500

N07BA03

ATC

varenicline; oral

1.7

53.5

1035

6223

KMAK, ,

NOMESCO Finland

1.2

53.4

11860

105859

H60.8

ICD-10 Finland

Other otitis externa

1.9

53.3

641

3339

N06AA10

ATC

nortriptyline; systemic

2.2

53.2

451

2063

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.2

53.2

462

2135

L40.9

ICD-10 Finland

Psoriasis, unspecified

2.5

53.2

338

1364

WX723, ,

SPAT

3.9

53.1

158

411

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

52.9

1320

8458

R35

ICD-10 Finland

Polyuria

1.7

52.9

1131

6978

R31

ICD-10 Finland

Unspecified haematuria

1.5

52.9

1558

10368

E11.09

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - With coma

7.4

52.8

103

M19.9

ICD-10 Finland

Arthrosis, unspecified

1.9

52.8

729

3973

A10BK02

ATC

canagliflozin; oral

4.4

52.6

131

298

SPAT1167

SPAT

Insertion of urinary catheter

2.2

52.6

454

2093

G63.2

ICD-10 Finland

Diabetic polyneuropathy

4.8

52.5

118

247

QBJ00

NOMESCO Finland

Liposuction in trunk

3.9

52.2

152

389

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

52.1

4125

32612

SFA00

NOMESCO Finland

Small restoration

1.4

52.0

2835

21185

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.7

52.0

284

1064

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

3.6

52.0

169

467

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.0

51.9

542

2687

L40.5

ICD-10 Finland

Arthropathic psoriasis

2.4

51.8

366

1550

N02AC04

ATC

dextropropoxyphene; oral

2.1

51.8

520

2541

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.6

51.8

306

1193

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

3.4

51.7

188

559

R03BB01

ATC

ipratropium bromide; inhalant

2.1

51.5

509

2473

M54.3

ICD-10 Finland

Sciatica

1.6

51.5

1146

7144

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.3

51.4

410

1830

N85.1

ICD-10 Finland

Endometrial adenomatous hyperplasia

3.1

51.4

210

671

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.1

51.2

475

2252

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.1

51.2

514

2512

W19

ICD-10 Finland

Unspecified fall

1.5

51.0

1751

12029

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

4.0

50.9

146

370

L05.9

ICD-10 Finland

Pilonidal cyst without abscess

2.7

50.9

276

1031

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.6

50.8

1175

7393

R06AX22

ATC

ebastine; oral

1.3

50.8

3666

28595

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

0.5

50.8

509

9866

C07AB12

ATC

nebivolol; oral

2.0

50.8

565

2866

K29.7

ICD-10 Finland

Gastritis, unspecified

1.9

50.7

649

3452

M54.1

ICD-10 Finland

Radiculopathy

1.8

50.6

788

4455

O82.0

ICD-10 Finland

Delivery by elective caesarean section

1.7

50.6

979

5884

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.8

50.6

794

4500

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.7

50.4

877

5120

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.6

50.4

1229

7831

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

50.4

572

2921

40199

ICD-8 Finland

Essential benign hypertension

2.9

50.4

232

794

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

50.4

1164

7322

C10AC01

ATC

colestyramine; oral

2.0

50.3

541

2710

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.8

50.3

258

936

ZYC01, ,

SPAT

1.5

50.3

1952

13735

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.6

50.3

1314

8510

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.6

50.2

1172

7389

A97

ICPC

No disease

1.3

50.2

3478

26960

SPAT1146

SPAT

Puncture of abscess or incision of skin

2.4

50.1

360

1536

M54.8

ICD-10 Finland

Other dorsalgia

1.7

50.1

915

5415

J35.1

ICD-10 Finland

Hypertrophy of tonsils

2.2

50.1

408

1837

M77.4

ICD-10 Finland

Metatarsalgia

1.6

50.0

1235

7893

S06.0

ICD-10 Finland

Concussion

1.4

49.9

2064

14695

JN4AD

NOMESCO Finland

Body CT examination

1.5

49.9

1709

11733

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.7

49.9

868

5068

H05BX01

ATC

cinacalcet; oral

4.0

49.8

142

358

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

23046

206403

2.39

322.61

5.6

4.0

4.43

4.75

mmol/l

307.65

21748

194185

(3013650) Neutrophils [#/volume] in Blood by Automated count

15099

119144

1.67

320.28

9.1

9.0

4.60

3.98

e9/l

198.15

13375

104584

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

23456

212053

2.58

315.67

20.1

12.1

20.88

22.15

mg/l

8.72

21404

163355

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

4138

22726

1.98

313.02

5.2

4.0

29.51

32.54

67.05

3301

16075

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

4859

28186

1.90

312.20

2.0

1.8

—

(3016502) Oxygen saturation in Arterial blood

3352

17083

2.11

311.46

8.9

7.8

94.81

96.07

27.24

3248

16434

(3024354) Oxygen [Partial pressure] in Venous blood

2682

12549

2.27

308.71

4.2

3.4

4.76

4.65

kpa

1.71

2604

12163

(3020779) Urea [Moles/volume] in Serum or Plasma

3156

15103

2.25

307.65

9.8

7.7

11.18

8.78

mmol/l

54.03

3008

14475

(3026008) Bacteria identified in Urine by Culture

8946

56933

1.89

307.65

3.4

2.7

—

(3018010) Neutrophils/100 leukocytes in Blood

13093

99422

1.66

307.65

6.5

5.9

58.62

56.55

86.41

12353

93771

(3006504) Eosinophils/100 leukocytes in Blood

12956

96911

1.69

307.65

6.5

6.0

2.79

2.85

2.65

12197

91042

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

12622

73887

2.42

307.65

2.4

1.8

95.44

97.65

pmol/l

6.04

7691

38482

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3280

9648

3.76

307.65

3.6

3.4

1.70

1.54

mmol/l

1.56

2454

7029

(3027801) Oxygen [Partial pressure] in Arterial blood

3714

19146

2.10

307.65

8.5

7.4

11.01

13.06

kpa

135.90

3556

18330

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1279

3442

3.86

307.65

1.8

2.3

1.06

0.80

nmol/l

20.78

1018

2945

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

4689

26086

1.98

307.65

1.9

1.8

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

23772

211351

3.28

307.65

23.2

13.2

139.71

139.64

mmol/l

5.01

23429

205998

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

10723

68250

2.00

307.65

4.5

3.1

47.58

61.84

ng/l

0.61

7228

40701

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

20154

153646

2.57

307.65

8.4

7.3

81.15

75.90

u/l

51.61

19288

145165

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3262

15458

2.28

307.65

4.9

4.0

5.94

5.81

kpa

9.49

3180

15036

(3003396) Base excess in Arterial blood by calculation

3715

19169

2.10

307.65

8.6

7.4

1.35

0.89

mmol/l

8.89

3046

15189

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

9864

61565

1.99

307.65

2.9

2.5

51.97

63.88

u/l

5.16

9135

57000

(3013826) Glucose [Moles/volume] in Serum or Plasma

17338

113646

2.69

307.65

6.2

4.4

7.19

6.53

mmol/l

209.79

16264

104927

(3022096) Basophils/100 leukocytes in Blood

12514

93691

1.67

307.65

6.6

6.1

0.64

0.69

27.57

11721

87692

(3013115) Eosinophils [#/volume] in Blood

14167

107019

1.74

307.65

6.6

6.1

0.21

0.19

e9/l

30.03

12638

94923

(3022313) Gas panel - Capillary blood

2586

7086

3.95

307.65

3.6

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

5859

22125

3.15

307.65

6.3

6.1

1.08

1.03

mmol/l

30.49

5570

20747

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3621

16900

2.33

307.65

2.3

2.4

0.22

g/l

0.42

3366

15807

(3012095) Magnesium [Moles/volume] in Serum or Plasma

6447

28858

2.66

307.65

3.2

3.6

0.82

mmol/l

0.04

6099

27140

(3023368) Bacteria identified in Blood by Culture

8228

46735

2.13

307.65

4.8

4.1

—

(3002032) Base excess in Venous blood by calculation

3237

15422

2.26

307.65

4.9

4.1

1.97

1.78

mmol/l

1.92

2778

13131

(3019069) Monocytes/100 leukocytes in Blood

13025

97475

1.70

307.65

6.9

6.3

8.04

8.42

39.74

12279

91760

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2197

6338

3.70

307.65

3.7

24.82

24.75

mmol/l

0.59

2069

5898

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

13320

82151

2.32

307.65

3.1

2.2

70.43

1168.14

nmol/l

0.50

12351

75122

(3026493) Urate [Moles/volume] in Serum or Plasma

9727

49489

2.57

307.65

2.9

2.4

3531.00

3617.64

umol/l

0.08

8567

43982

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

22469

197647

2.28

307.65

5.1

3.6

1.63

1.25

mmol/l

307.65

20945

184220

(3002030) Lymphocytes/100 leukocytes in Blood

13278

100865

1.67

307.65

6.7

6.0

27.23

28.87

64.85

12543

95203

(3024561) Albumin [Mass/volume] in Serum or Plasma

13987

79574

2.71

307.65

5.5

4.8

35.51

36.08

g/l

31.05

13239

74033

(3001122) Ferritin [Mass/volume] in Serum or Plasma

13781

96207

1.96

307.65

3.8

2.8

111.60

108.79

ug/l

0.70

12953

90341

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

22987

184392

3.87

307.65

9.3

4.8

43.06

38.59

mmol/mol

307.65

21876

172272

(3042936) Bacteria identified in Isolate by Culture

4890

26503

2.05

307.65

2.4

1.9

—

(3021960) Folate [Moles/volume] in Serum or Plasma

7762

39982

2.36

307.65

1.7

1.5

20.40

20.43

nmol/l

0.04

6872

34545

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

9199

43995

2.72

307.65

3.5

2.8

1190.31

1112.53

ng/l

0.96

7567

37283

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3715

19158

2.10

307.65

8.6

7.4

5.30

5.04

kpa

39.79

3565

18339

(3022948) Iron [Moles/volume] in Serum or Plasma

5720

28898

2.27

307.65

3.1

2.4

12.49

14.62

umol/l

2.59

5338

27087

(3031040) Bacteria [#/volume] in Urine by Automated count

16918

135810

1.75

307.65

5.3

4.0

1420.28

1401.72

e6/l

0.02

328

1662

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

20523

164925

2.33

307.65

5.1

4.0

14.62

14.58

pmol/l

1.59

19070

151929

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

22954

204999

2.37

307.65

5.6

3.9

1.26

1.49

mmol/l

307.65

21558

192187

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

5025

24351

2.33

307.65

3.1

2.5

20.67

23.77

49.41

4362

20925

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

13733

98266

1.88

307.65

2.9

2.5

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

5375

26402

2.32

307.65

3.0

2.4

2.48

2.37

g/l

34.99

4964

24531

(3013512) EKG study

8666

51748

2.03

307.65

4.8

3.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

11833

51987

3.41

307.65

4.6

3.8

12.39

8.88

mg/mmol

8.72

8145

32565

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

8769

46430

2.36

307.65

2.7

2.2

3.19

2.78

mg/l

46.55

7816

39757

(3009343) pH of Capillary blood

3390

9994

3.76

307.65

3.6

3.4

7.40

7.42

5.97

381

1360

(3007853) Bacteria identified in Skin by Aerobe culture

4501

22776

2.19

307.65

2.0

1.7

—

(3037467) Urinalysis macro (dipstick) panel - Urine

17979

142847

1.91

307.65

5.1

4.0

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

22871

194968

2.91

307.65

6.3

4.6

2.00

2.08

mu/l

0.28

21504

181317

(3019309) Folate [Moles/volume] in Red Blood Cells

6544

29803

2.62

307.65

2.1

1.7

1227.14

1161.05

nmol/l

6.78

5332

22714

(3019198) Lymphocytes [#/volume] in Blood

14009

106856

1.70

307.65

6.4

5.9

2.05

1.95

e9/l

8.11

12604

95593

(3036481) Cortisol [Moles/volume] in Serum or Plasma

4208

18173

2.58

307.65

2.0

2.2

338.63

378.96

nmol/l

33.64

3846

16871

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

7371

38110

2.32

307.65

2.0

1.6

33959394.30

38401205.68

pmol/l

0.24

6340

32153

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

17916

145249

1.81

307.65

4.1

2.9

58.01

42.96

u/l

70.24

16823

137150

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3417

10121

3.75

307.65

3.7

3.4

5.26

5.09

kpa

24.03

3258

9618

(3009508) Creatinine [Moles/volume] in Urine

11846

55983

3.11

307.65

3.7

3.2

7.99

8.01

mmol/l

0.02

10001

48069

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1138

3270

3.60

307.65

3.7

3.0

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

23787

211982

3.25

307.65

23.4

13.3

3.97

3.94

mmol/l

42.47

23406

206170

(3012544) pH of Venous blood

3362

16008

2.27

307.65

4.9

4.1

7.37

7.38

0.72

105

(3044640) Blood type and Crossmatch panel - Blood

9727

63806

1.86

307.65

2.5

2.3

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

14112

91808

2.22

307.65

8.3

6.4

1.21

mmol/l

14.92

12087

78200

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

12671

83036

2.06

307.65

7.6

5.7

1.21

mmol/l

13.41

11678

76142

(3015377) Calcium [Moles/volume] in Serum or Plasma

9484

63248

1.80

307.65

3.0

3.4

2.34

2.35

mmol/l

12.86

8350

56358

(3013707) Erythrocyte sedimentation rate by Westergren method

18559

153168

1.81

307.65

4.8

3.9

15.85

10.51

mm/h

307.65

17274

142958

(3022217) INR in Platelet poor plasma by Coagulation assay

13453

82736

2.35

307.65

16.2

11.8

1.23

1.20

inr

1.98

4041

25031

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1302

4028

3.35

307.65

3.6

2.9

25.02

24.44

mmol/l

4.61

1278

3940

(3012516) Albumin [Mass/volume] in Urine

11228

49623

3.28

307.65

3.7

3.3

235.90

447.92

mg/l

7.94

7803

31189

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

23328

209129

2.59

307.65

6.1

4.3

2.64

2.84

mmol/l

219.82

21955

195701

(3016244) Insulin [Units/volume] in Serum or Plasma

1035

988

10.88

307.65

3.9

2.6

43.58

16.67

mu/l

44.70

993

917

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11045

67362

2.14

307.65

3.4

3.2

32.78

32.76

u/l

0.01

10461

64121

(3006315) Basophils [#/volume] in Blood

13745

103473

1.72

307.65

6.3

5.9

0.04

e9/l

8.58

12075

90487

(40760892) CBC W Ordered Manual Differential panel - Blood

13070

97436

1.71

307.65

6.9

6.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1268

3893

3.38

307.65

2.4

140.41

98.80

ug/min

2.15

785

2379

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

14903

100367

2.19

307.65

5.8

6.1

10.55

10.98

umol/l

3.93

14145

95106

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

7468

44973

1.94

307.65

2.0

1.8

1.05

1.11

mg/l

0.85

5822

33823

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

22974

199066

2.78

307.65

6.3

4.0

6.43

5.77

mmol/l

307.65

21461

184239

(3001604) Monocytes [#/volume] in Blood

13705

103282

1.72

307.65

6.3

5.9

0.60

0.56

e9/l

73.03

12067

90432

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

817

1966

4.26

304.51

1.2

24.33

32.18

nmol/l

0.63

(3026782) Osmolality of Urine

5967

37193

1.79

302.69

3.4

2.7

560.27

539.61

mosm/kgh2o

8.24

5212

31911

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

7290

48368

1.71

295.47

2.5

2.2

—

(4146454) Self-monitoring of blood glucose

697

1563

4.56

284.30

2.7

2.8

—

(3018418) pH of Serum or Plasma

7940

54430

1.67

281.80

4.9

4.0

7.40

0.93

1715

10374

(40768797) Stomach Pathology biopsy report

4566

26754

1.86

280.95

1.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

22063

196458

2.00

277.89

17.8

11.0

85.55

86.00

ml/min/173m2

1.93

18947

161380

(3019060) Gas panel - Arterial blood

2319

10673

2.29

276.18

5.4

4.9

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1825

7590

2.51

272.69

4.3

3.4

25.36

25.18

mmol/l

1.40

1786

7361

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2631

12817

2.18

272.48

4.6

3.9

103.86

85.62

ng/l

13.18

2275

11265

(3035350) Ketones [Presence] in Urine by Test strip

13078

102325

1.58

262.94

4.3

3.3

0.00

estimate

0.04

3171

20382

(3021901) Oxygen saturation in Capillary blood

961

2882

3.43

260.59

3.1

2.7

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

7993

55795

1.63

259.24

2.3

2.1

190.04

199.86

u/l

0.44

7529

52558

(3019225) pH of Specimen

3267

17601

1.98

257.01

4.5

4.0

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1689

6965

2.53

256.50

5.3

3.7

49.41

49.06

0.22

1675

6890

(3009261) Glucose [Presence] in Urine by Test strip

13148

103406

1.57

255.28

4.4

3.3

0.01

0.00

estimate

0.84

2800

19244

(3004119) Hemoglobin [Mass/volume] in Venous blood

2135

9909

2.26

248.13

4.3

3.3

130.13

129.83

g/l

0.23

2089

9686

(3021601) Nitrite [Presence] in Urine by Test strip

13005

102438

1.56

247.64

5.8

4.5

0.00

estimate

0.04

3018

19670

(3028626) Oxygen [Partial pressure] in Capillary blood

1128

3867

3.01

244.55

3.3

3.2

8.32

8.57

kpa

4.86

1106

3780

(3002582) Erythrocytes [#/volume] in Urine

8144

57897

1.60

240.91

3.7

3.0

75.61

81.81

e6/l

0.15

6447

43770

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

7423

51650

1.62

239.81

1.7

1.6

1.74

1.34

mmol/l

116.08

6124

44047

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

955

3046

3.22

234.18

1.1

41.45

3873.42

iu/ml

0.67

211

722

(3018095) Leukocytes [#/volume] in Urine

9389

69635

1.56

227.81

4.3

3.5

82.78

83.77

e6/l

0.05

6900

47574

(3021589) Normoblasts [#/volume] in Blood

11766

91938

1.53

223.12

11.8

8.9

0.00

e9/l

2.45

9847

75587

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

24091

225052

2.67

221.97

13.5

9.5

30.83

25.99

u/l

165.20

23529

218016

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2937

16034

1.94

219.98

9.8

8.2

124.70

121.73

g/l

11.26

2881

15581

(3020564) Creatinine [Moles/volume] in Serum or Plasma

23948

223666

2.48

210.47

22.7

13.6

78.86

73.60

umol/l

54.67

23942

223584

(3000991) Gas panel - Venous blood

2708

14612

1.96

209.32

10.3

8.6

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

592

1486

4.06

208.08

1.5

1.3

1.76

1.35

nmol/l

11.68

544

1321

(3000850) Epithelial cells [#/volume] in Urine

5878

39887

1.62

204.40

3.1

2.5

7.77

5.88

e6/l

16.45

5320

35653

(3027945) Reticulocytes/100 erythrocytes in Blood

3251

18816

1.84

201.95

2.6

1.99

1.73

29.73

2872

16845

(3015736) pH of Urine

10670

82837

1.50

201.25

3.9

3.1

5.73

5.90

5.74

660

7650

(3030467) Casts [#/volume] in Urine by Automated count

7386

53028

1.56

201.04

3.6

3.0

0.50

0.36

e6/l

4.72

5802

39679

(1616796) Gas panel - Central venous blood

1043

3847

2.79

197.15

4.7

3.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

433

894

4.91

195.08

2.0

1.5

1.63

1.11

nmol/l

12.79

333

711

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

210

201

10.53

191.28

1.0

1.1

73.13

88.20

ug/l

3.98

190

158

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1424

6193

2.38

191.14

2.2

2.0

1.92

2.16

ug/l

0.42

1267

5515

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2645

14693

1.89

186.09

5.0

3.6

1.22

1.23

mmol/l

14.69

2352

12841

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

10218

79548

1.48

184.90

4.6

3.4

—

(3008037) Lactate [Moles/volume] in Venous blood

906

3221

2.88

183.32

3.9

2.8

1.64

1.53

mmol/l

2.51

892

3142

(3037522) Nuclear Ab [Titer] in Serum

4590

29982

1.65

183.31

1.4

460.28

548.24

titre

2.75

870

6123

(3014111) Lactate [Moles/volume] in Serum or Plasma

2694

15187

1.87

180.73

8.9

7.1

1.46

1.32

mmol/l

6.85

2622

14856

(3038515) Glucose [Moles/volume] in Venous blood

860

3023

2.91

177.62

4.1

2.9

7.89

7.46

mmol/l

3.31

847

2960

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1620

7668

2.19

177.43

3.7

3.0

1.43

1.29

3.98

1615

7627

(3033658) Prothrombin time (PT) actual/Normal

6907

49950

1.53

177.19

4.5

3.8

92.37

92.76

0.58

6699

48642

(1002224) Polysomnography panel

1794

8847

2.11

176.82

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

4261

27737

1.65

171.17

2.0

1.7

1.46

1.41

4.87

3716

24685

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1773

8817

2.09

170.71

10.7

9.7

24.55

24.18

mmol/l

4.38

1705

8602

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2383

13161

1.90

169.85

3.0

2.7

165.39

169.14

ng/l

0.18

2112

11950

(40761511) CBC panel - Blood by Automated count

23735

223000

2.14

169.07

19.6

11.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2004

10485

1.99

167.59

8.5

7.0

25.00

24.47

mmol/l

7.08

1932

9962

(3044889) 12 lead EKG panel

16151

138693

1.46

167.29

4.3

3.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2346

12964

1.89

166.77

1.7

1.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

7639

57153

1.48

163.40

4.1

2.9

—

(3029937) Albumin [Presence] in Urine by Test strip

7346

54557

1.49

162.92

4.7

3.7

0.01

0.00

estimate

1.05

2839

19128

(36304419) Bacteria [Presence] in Urine

7070

52306

1.49

158.99

3.5

2.9

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3114

18992

1.73

158.94

1.9

1.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

3550

22499

1.67

156.94

2.7

2.8

7.76

8.08

umol/l

0.39

2975

19409

(3010421) pH of Blood

1089

4594

2.43

155.89

5.3

3.5

7.41

7.42

5.35

1002

4206

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1431

6792

2.17

155.13

5.9

4.9

1.80

1.69

2.05

1373

6333

(3013290) Carbon dioxide [Partial pressure] in Blood

977

3960

2.53

152.40

5.4

3.5

5.14

4.96

kpa

9.71

956

3883

(3027315) Oxygen [Partial pressure] in Blood

981

3985

2.52

152.31

5.4

3.5

8.57

8.81

kpa

4.50

960

3907

(3012501) Base excess in Blood by calculation

976

3959

2.52

151.99

5.3

3.5

2.71

2.33

mmol/l

3.50

678

2598

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2034

11044

1.92

151.95

8.2

7.1

24.88

24.70

mmol/l

1.29

2014

10963

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3101

19141

1.71

150.94

1.9

1.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3016

18477

1.72

150.89

4.1

3.0

—

(3017181) Myelocytes/100 leukocytes in Blood

2767

16561

1.75

150.43

4.2

4.1

0.80

0.94

2.21

971

5299

(3021440) Promyelocytes/100 leukocytes in Blood

2655

15761

1.77

148.41

4.2

0.08

0.11

1.81

860

4519

(3020630) Protein [Mass/volume] in Serum or Plasma

2364

13571

1.82

147.96

2.0

2.6

66.98

66.72

g/l

0.90

2148

12491

(3007930) Methemoglobin/Hemoglobin.total in Blood

1391

6687

2.14

145.75

6.0

5.0

0.85

0.91

8.12

1336

6240

(1761482) Bacteria [#/volume] in Urine by Culture

970

4006

2.48

145.31

4.5

3.7

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1172

5270

2.28

144.84

3.4

0.34

0.35

u/ml

0.16

695

2982

(3028026) IgM [Mass/volume] in Serum or Plasma

2120

11849

1.86

144.50

1.6

1.9

1.15

1.34

g/l

7.95

1932

10894

(3023520) Reticulocytes [#/volume] in Blood

2384

13825

1.80

144.08

2.6

81.08

69.30

e9/l

34.85

1829

10339

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1960

10708

1.90

143.37

10.9

9.3

0.64

0.68

4.49

1946

10651

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1963

10731

1.90

143.31

10.8

9.2

1.45

1.38

2.20

1945

10665

(3034770) Mitochondria Ab [Titer] in Serum

1217

5586

2.24

143.12

1.2

1.3

738.57

943.22

titre

0.68

174

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3185

20204

1.66

138.92

3.4

4.4

235.95

239.49

u/l

0.72

3009

19190

(3014007) Fractional oxyhemoglobin in Arterial blood

1950

10767

1.88

137.83

11.0

9.4

93.11

94.19

12.69

1942

10732

(3007566) Smooth muscle Ab [Titer] in Serum

1217

5685

2.20

136.96

1.2

1.3

120.00

120.07

titre

0.00

119

543

(4200892) Spirometry reversibility

2358

13864

1.77

135.58

1.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

2526

15159

1.74

135.18

3.9

4.0

0.60

0.70

1.48

845

4596

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1909

10555

1.88

134.22

1.7

1.5

—

(40767503) Oxygen content in Capillary blood by calculation

890

3668

2.48

133.81

3.1

2.4

16.63

16.65

0.05

539

1829

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1789

9709

1.91

133.19

1.8

1.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

2559

15479

1.73

133.00

2.3

2.7

10.67

10.50

g/l

1.17

2330

14220

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

5036

35900

1.50

131.57

1.3

9.02

11.37

u/ml

1.88

1958

14525

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1482

7572

2.02

131.55

2.0

—

(3025159) Blasts/100 leukocytes in Blood

2499

15087

1.73

130.66

4.3

4.1

0.08

0.35

2.91

713

3878

(3006184) Hemoglobin [Mass/volume] in Capillary blood

930

3956

2.40

130.42

2.5

2.1

131.61

131.01

g/l

0.30

729

2877

(3007164) IgA [Mass/volume] in Serum or Plasma

5883

43333

1.47

130.28

1.5

1.4

2.60

2.29

g/l

25.77

3676

27093

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1590

8401

1.95

128.10

5.3

4.6

24.11

24.08

mmol/l

0.13

1549

8251

(3000494) Fungus identified in Specimen by Culture

3531

23434

1.59

127.21

1.5

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

5248

38014

1.48

125.89

1.4

1.3

32.93

33.25

iu/ml

0.03

1505

12349

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

6650

50402

1.43

125.65

1.3

1.54

1.63

u/ml

0.26

1855

14077

(3033705) Calcium.ionized [Moles/volume] in Venous blood

527

1709

3.13

125.24

2.8

2.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

926

4008

2.36

124.82

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1400

7175

2.01

123.01

1.4

1.3

8.76

10.40

u/l

5.67

1142

5901

(3018405) Lactate [Moles/volume] in Arterial blood

1196

5789

2.12

122.71

4.5

4.2

1.42

1.36

mmol/l

0.95

1172

5689

(3004588) Protein electrophoresis panel - Serum or Plasma

1927

10982

1.82

122.51

1.8

2.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1349

6873

2.02

120.45

1.9

1.8

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2335

14135

1.72

120.37

3.1

3.4

4.48

4.52

pmol/l

1.44

2049

12731

(3013139) Helicobacter pylori Ag [Presence] in Stool

2305

13936

1.72

119.31

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1448

7607

1.96

118.39

1.8

1.67

1.47

g/l

12.29

1247

6575

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1593

8670

1.89

117.10

2.0

1.6

5.15

3.64

mg/l

4.81

1497

5966

(3020876) Protein [Mass/time] in 24 hour Urine

534

1823

2.97

116.04

2.7

2.5

1.76

1.26

g/24h

3.52

306

906

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

992

4616

2.20

112.41

1.3

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1503

8133

1.90

112.34

1.4

1.6

11.53

13.66

u/ml

0.31

229

(3020891) Body temperature

1292

6654

1.99

111.73

5.9

4.8

—

(3004775) Volume in Urine collected for unspecified duration

423

1288

3.32

111.57

2.3

746.45

659.23

2.74

290

919

(3037121) Protein [Mass/volume] in Urine

1235

6265

2.02

111.44

3.0

3.3

0.42

0.31

g/l

2.82

554

2773

(3017143) Hepatitis C virus Ab [Presence] in Serum

3991

27966

1.51

110.95

1.7

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

5578

41777

1.43

109.85

1.8

1.7

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

337

894

3.81

109.59

1.6

2.48

11.98

nmol/l

0.86

274

749

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

4771

34722

1.46

109.55

4.2

3.4

341.61

515.87

ng/l

1.85

3437

24286

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

814

3530

2.35

109.12

1.2

67.69

164.66

titre

1.40

(3027456) Digoxin [Moles/volume] in Serum or Plasma

596

2262

2.67

106.12

3.1

3.0

0.81

0.82

nmol/l

0.16

466

1680

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

4516

32700

1.46

106.01

2.6

3.0

2.45

2.44

mmol/l

6.56

3856

28726

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

724

3083

2.39

101.11

1.7

1.6

—

(3011985) Renin [Units/volume] in Plasma

644

2601

2.51

100.94

1.5

1.6

78.94

59.89

mu/l

1.53

561

2337

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3984

28409

1.48

100.54

2.3

2.2

30.20

29.60

7.18

3860

27577

(3000330) Specific gravity of Urine by Test strip

1560

8872

1.81

99.18

4.0

3.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

520

1916

2.75

98.09

9.2

8.5

8.32

7.11

mmol/l

2.43

429

1584

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1429

7960

1.84

97.18

1.5

1.7

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1653

9633

1.77

96.68

3.1

2.6

0.36

0.25

e6/l

2.20

1628

9329

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1220

6476

1.93

96.33

1.6

108.60

323.17

titre

6.27

252

(3023183) Ammonium ion [Moles/volume] in Plasma

814

3732

2.22

95.55

3.4

2.8

36.71

33.70

umol/l

2.60

762

3402

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4146

30156

1.45

93.66

3.1

2.8

5.18

2.92

e6/l

5.85

2333

15923

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1603

9457

1.74

89.61

12.1

9.6

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4374

32379

1.42

89.26

2.9

2.6

1.39

1.14

e6/l

1.55

2547

18038

(3021387) Prolactin [Units/volume] in Serum or Plasma

1652

9853

1.72

88.79

1.6

302.67

310.80

mu/l

0.42

1487

8856

(3043409) Potassium [Moles/volume] in Arterial blood

992

5046

2.01

88.54

5.0

4.4

3.92

3.86

mmol/l

3.12

982

5007

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

852

4111

2.11

87.79

1.4

1.3

17.73

26.92

u/l

19.82

682

3376

(3028717) Thiamine [Mass/volume] in Blood

120

156

7.72

86.33

1.3

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

936

4714

2.02

85.88

2.3

3.5

2.55

2.91

ratio

0.13

376

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

955

4860

2.00

85.10

2.3

3.6

39.12

41.65

mg/l

0.30

714

3967

(3034860) Kappa light chains.free [Mass/volume] in Serum

955

4864

2.00

84.90

2.3

3.6

54.74

62.21

mg/l

0.27

720

3966

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

576

2405

2.43

84.00

1.3

1.4

321.23

400.58

pmol/l

1.04

510

2099

(3019150) Specific gravity of Urine by Refractometry

5645

44050

1.36

83.21

4.6

3.6

1.02

kg/l

3.52

962

6566

(3016750) Collection duration of Urine

316

966

3.30

82.89

2.2

496.65

499.91

min

0.21

230

750

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

387

1346

2.90

81.36

1.3

5.49

5.20

umol/l

0.69

356

1238

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1013

5350

1.93

81.01

2.0

1.7

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

107

131

8.20

80.96

2.0

1.8

1.30

1.34

umol/l

0.73

102

113

(3003694) ABO and Rh group [Type] in Blood

7867

64706

1.31

80.41

1.6

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

24535

238501

2.18

80.01

30.0

17.9

40.35

40.46

0.90

23425

225401

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2141

14014

1.58

79.35

2.4

2.2

6.00

7.76

ug/l

4.67

1814

12412

(3028271) Lactate [Moles/volume] in Capillary blood

627

2793

2.28

78.85

2.3

1.8

1.74

1.70

mmol/l

0.42

617

2728

(3005322) IgE [Units/volume] in Serum or Plasma

2190

14440

1.57

78.58

1.3

278.58

224.26

u/ml

0.90

2050

13365

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1046

5694

1.87

76.20

2.0

1.7

32.07

43.90

nmol/l

38.60

1002

5554

(40758558) Short blood count panel - Blood

6389

51340

1.33

76.17

6.4

6.9

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2126

14032

1.56

75.82

2.9

2.1

8.64

12.20

nmol/l

88.97

1859

12691

(3007461) Platelets [#/volume] in Blood

24534

238745

2.13

75.52

29.9

17.9

263.50

255.81

e9/l

62.82

24173

233274

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1438

8625

1.71

75.39

2.1

2.0

38.61

39.44

u/l

0.82

1279

7781

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

978

5253

1.90

74.25

3.6

4.0

1.88

1.41

mg/l

36.48

887

4892

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

579

2562

2.29

73.98

1.2

1.3

37.02

31.55

u/l

0.29

494

2235

(3035941) MCH [Entitic mass]

24540

238932

2.12

73.68

29.7

17.8

29.75

30.25

307.65

24334

236210

(3010813) Leukocytes [#/volume] in Blood

24544

239008

2.12

73.29

29.9

17.9

7.46

6.63

e9/l

307.65

24124

232954

(3024731) MCV [Entitic volume]

24539

238964

2.11

72.90

29.8

17.8

90.00

90.66

90.05

24334

236227

(3026361) Erythrocytes [#/volume] in Blood

24540

238986

2.11

72.75

29.9

17.8

4.57

4.51

e12/l

78.56

24132

232985

(3000963) Hemoglobin [Mass/volume] in Blood

24543

239069

2.10

72.01

30.1

17.9

135.08

135.72

g/l

9.76

24348

236361

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

962

5210

1.88

71.16

1.5

1.4

14.78

15.48

iu/ml

0.04

112

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

890

4706

1.92

70.83

1.5

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

485

2026

2.42

70.68

1.1

1.0

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1074

6037

1.81

70.51

2.3

631.34

525.66

ug/l

0.18

1003

5581

(3002385) Erythrocyte distribution width [Ratio]

19948

186590

1.33

70.23

22.7

14.4

15.59

14.92

10.69

19753

183457

(40760888) Immunoglobulin light chains.free panel - Serum

740

3692

2.03

69.61

2.3

3.6

—

(3025941) Bacteria identified in Stool by Culture

1912

12567

1.56

69.19

1.3

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

760

3840

2.01

69.01

2.2

1.8

152.14

192.06

pmol/l

21.27

707

3659

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

596

2765

2.18

67.88

1.2

1.3

0.20

0.22

nmol/l

0.14

165

(40761536) Microorganisms panel - Urine sediment

2567

18048

1.47

67.37

4.9

3.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

814

4269

1.94

66.37

1.4

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

512

2262

2.29

65.67

7.3

6.3

11.14

11.33

mg/l

0.44

469

2087

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1872

12390

1.55

65.55

2.4

2.2

5961.30

6100.80

u/l

0.07

697

5043

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

591

2775

2.16

65.29

1.2

1.3

1.25

1.45

nmol/l

0.08

573

2673

(3000570) Elastase.pancreatic [Mass/mass] in Stool

982

5516

1.81

64.56

1.4

283.29

281.22

ug/g

0.11

539

3099

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

579

2715

2.16

64.19

1.1

1.50

1.49

g/l

0.25

518

2473

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

420

1720

2.47

63.95

1.7

2.3

18.53

19.76

nmol/l

1.87

389

1642

(3022806) Fractional oxyhemoglobin in Capillary blood

510

2278

2.26

63.74

2.2

1.7

89.32

90.29

3.19

503

2243

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

542

2493

2.20

63.07

1.2

1.3

—

(3024928) Oxygen saturation in Venous blood

708

3618

1.98

62.25

4.1

3.5

—

(3012565) Volume of 24 hour Urine

269

895

3.03

61.31

2.3

2.1

1923.50

2022.94

0.80

247

815

(3035637) Corticotropin [Mass/volume] in Plasma

537

2490

2.18

61.25

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

5774

46929

1.30

60.75

1.7

1.6

—

(21494755) Public health laboratory ask at order entry panel

1816

26487

0.66

60.50

1.3

—

(3017732) Neutrophils [#/volume] in Blood

2116

14639

1.49

59.88

3.1

2.6

5.01

4.64

e9/l

1.00

1677

12210

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

482

2162

2.25

59.66

2.2

2.0

23.78

25.28

mg/l

0.23

157

559

(3003129) Base excess in Capillary blood by calculation

158

377

4.21

59.63

1.6

1.7

0.76

0.57

mmol/l

0.22

150

351

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

539

2534

2.15

59.37

1.4

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

525

2444

2.17

59.30

1.4

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

525

2447

2.17

59.11

1.4

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

530

2480

2.16

59.09

1.4

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

525

2449

2.17

58.99

1.4

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2355

16751

1.45

57.65

1.2

129.98

147.44

iu/ml

1.24

850

6469

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

151

358

4.24

57.49

1.5

1.4

5.76

5.62

nmol/l

0.15

143

340

(3001186) Copper [Moles/volume] in Serum or Plasma

175

466

3.77

56.81

1.7

1.2

17.64

16.86

umol/l

1.18

160

408

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

472

2150

2.22

56.29

1.4

8.90

7.79

mmol/l

6.05

450

2080

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

522

2478

2.13

56.10

1.4

1.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

645

3309

1.97

56.08

1.6

1.3

7.40

6.89

mmol/l

4.52

570

2992

(3022145) Colonoscopy Study observation

3039

22730

1.38

55.74

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

6067

50096

1.28

55.48

1.9

—

(3017569) Oxygen content in Arterial blood

213

656

3.27

55.35

2.0

2.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

741

3999

1.88

55.35

4.5

3.1

24.62

26.20

mg/l

0.52

505

2458

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1079

6532

1.68

54.35

1.5

1.8

0.27

0.23

g/l

36.04

1032

6210

(3024666) Lithium [Moles/volume] in Serum or Plasma

330

1306

2.55

54.09

12.8

11.8

0.61

0.62

mmol/l

0.42

298

1201

(3048689) Calprotectin [Mass/mass] in Stool

3650

28222

1.34

53.99

2.4

143.26

122.14

ug/g

2.98

2876

22243

(3020491) Glucose [Moles/volume] in Blood

361

1492

2.44

53.94

2.1

1.7

7.08

6.37

mmol/l

3.36

244

1125

(3004809) Band form neutrophils/100 leukocytes in Blood

570

2870

2.01

52.28

2.6

3.3

1.31

1.56

1.02

498

2601

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

230

773

2.99

51.58

2.0

2.1

222.33

82.89

ug/min

0.71

167

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2515

18448

1.40

51.54

2.7

2.5

34.76

43.63

u/l

1.25

2084

15929

(3000475) Leukocytes [#/volume] in Synovial fluid

773

4324

1.81

51.47

1.8

1.6

12719.32

12776.07

e6/l

0.01

557

3174

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

935

5533

1.72

51.22

2.2

2.1

10.82

10.65

mg/l

0.26

869

5182

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1094

6755

1.65

51.02

1.5

1.8

1.34

1.15

g/l

69.01

1048

6437

(3019977) pH of Arterial blood

248

875

2.85

50.95

2.8

2.5

7.41

7.42

0.84

278

(3020717) Zinc [Moles/volume] in Serum or Plasma

274

1021

2.70

50.74

1.7

1.5

14.86

27.72

umol/l

17.37

265

976

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

471

2264

2.10

49.03

1.6

1.5

56.21

54.48

0.37

296

1415

(3021788) Differential panel - Synovial fluid

621

3304

1.90

48.48

1.6

1.5

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

338

1425

2.39

48.38

1.1

1.2

—

34.10

u/ml

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1009

6203

1.65

47.84

1.8

2.3

7.81

7.24

g/l

20.65

915

5651

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1007

6188

1.65

47.83

1.8

2.3

4.01

3.64

g/l

14.32

916

5639

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1008

6196

1.65

47.82

1.8

2.3

—

(3022621) pH of Urine by Test strip

1841

12931

1.46

47.79

3.3

2.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3010

22993

1.35

47.75

7.6

6.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

239

861

2.79

47.27

2.2

163.49

147.88

umol/l

0.25

127

417

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

618

3316

1.89

47.01

1.8

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

356

1574

2.28

45.70

3.8

2.9

60.84

55.65

mg/l

0.15

276

1103

(3000492) Spirometry study

2801

21305

1.35

45.55

1.5

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

208

711

2.94

45.33

2.2

2.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

5665

47405

1.25

44.47

4.1

3.3

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

372

1695

2.21

44.42

1.6

1.5

30.31

33.79

0.94

227

1036

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

180

574

3.15

44.27

1.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

350

1561

2.26

44.02

1.1

294.21

290.62

mg/l

0.41

300

1423

(3010838) Calcium [Moles/time] in 24 hour Urine

636

3520

1.83

43.87

2.1

1.9

5.29

5.23

mmol/24h

0.14

576

3157

(40761535) Cells panel - Urine sediment

2071

15092

1.41

43.74

3.9

3.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

745

4327

1.74

43.63

1.5

1.7

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

931

5779

1.63

42.46

1.8

2.3

10.21

10.13

g/l

0.23

833

5194

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

553

2959

1.89

42.46

1.2

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

543

2908

1.89

41.59

1.3

—

(3037756) Immunofixation for Serum or Plasma

595

3280

1.83

41.58

1.4

1.8

—

(3044927) Protein electrophoresis panel - Urine

332

1484

2.25

41.57

1.3

1.2

—

(3047181) Lactate [Moles/volume] in Blood

925

5769

1.63

41.39

7.7

5.5

1.40

1.27

mmol/l

4.43

841

5100

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

653

3722

1.77

40.84

1.5

1.6

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

641

3658

1.77

39.93

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

640

3657

1.77

39.69

1.4

1.3

—

(3001556) Androgen free Index in Serum or Plasma

100

239

4.20

37.82

1.3

1.1

—

(3014271) Vancomycin [Susceptibility]

182

640

2.86

37.76

3.0

2.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

705

4223

1.69

36.92

1.5

1.7

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

465

2469

1.90

36.61

1.8

1.6

8.57

7.52

mmol/l

18.19

433

2382

(3009466) Valproate [Moles/volume] in Serum or Plasma

515

2829

1.84

36.45

6.2

5.1

355.27

374.36

umol/l

2.09

458

2467

(3000012) Reticulocyte production index

432

2242

1.94

36.43

2.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

248

1042

2.39

35.91

1.3

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

251

1061

2.38

35.85

1.3

1.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

915

5891

1.57

35.83

1.9

2.4

2.98

2.89

g/l

2.07

823

5341

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

296

1346

2.21

35.62

18.3

17.6

3916.31

2148.73

nmol/l

0.31

284

1290

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1292

8959

1.47

35.62

1.3

0.25

1.06

u/ml

8.34

138

742

(3004451) EKG impression Narrative

193

723

2.68

35.54

1.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1034

6857

1.53

35.45

1.6

1.9

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

284

1278

2.24

35.07

13.3

12.7

837.35

836.49

nmol/l

0.01

271

1238

(3023511) Choriogonadotropin [Units/volume] in Urine

963

6316

1.55

34.73

1.4

1.3

—

(3045424) Erythrocytes [Presence] in Urine

592

3439

1.74

34.69

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

715

4370

1.65

34.68

2.5

2.8

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

206

812

2.55

34.24

1.3

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

206

812

2.55

34.24

1.3

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

382

1942

1.98

34.23

2.9

3.7

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

134

419

3.21

34.17

1.2

332.16

350.01

pmol/l

0.12

318

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

535

3078

1.75

32.46

1.5

1.8

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

128

403

3.19

32.30

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

595

3532

1.70

32.27

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

480

2680

1.81

32.26

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

174

652

2.68

32.08

2.4

—

(3044941) Cell count panel - Synovial fluid

489

2755

1.79

31.89

1.5

1.4

—

(40768804) Tissue Pathology biopsy report

9565

86234

1.18

31.88

2.0

—

(40768441) Liver Pathology biopsy report

303

1456

2.09

31.74

1.4

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

676

4167

1.64

31.73

3.1

3.4

4.64

3.97

e9/l

10.93

676

4159

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

821

5319

1.56

31.29

2.0

2.4

0.49

0.82

g/l

3.82

709

4631

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1749

23080

0.74

31.14

1.7

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

955

6403

1.51

31.09

2.5

2.7

4.02

3.53

g/l

18.41

912

6091

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

866

5696

1.54

30.84

2.5

2.7

—

(3036489) Thrombin time

1137

7911

1.46

30.76

1.9

2.2

21.29

21.36

0.12

941

6828

(3023419) Bacteria identified in Sputum by Culture

460

2581

1.80

30.44

2.5

—

(3006270) Folate [Moles/volume] in Blood

300

1465

2.06

30.13

1.2

1.1

374.92

377.60

nmol/l

0.08

229

1305

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1105

15635

0.69

30.12

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

856

5646

1.53

30.10

3.2

3.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

418

2287

1.84

30.05

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

538

3186

1.70

29.47

1.5

—

(1761868) Lipid panel - Serum or Plasma

8953

80654

1.17

29.36

3.6

2.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1814

13773

1.34

29.24

1.4

1.3

19.64

27.45

iu/l

30.14

1517

11934

(3039000) Anion gap in Blood

634

3943

1.62

28.74

9.2

6.6

11.41

11.21

mmol/l

0.78

585

3543

(3018572) Chloride [Moles/volume] in Blood

634

3944

1.62

28.71

9.2

6.6

105.22

105.29

mmol/l

0.15

585

3544

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

371

1989

1.88

28.46

1.2

58.19

63.06

u/l

0.81

338

1785

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

242

1116

2.18

28.24

1.4

1.5

18.51

22.41

u/ml

0.84

222

(3010144) Erythrocytes [#/volume] in Synovial fluid

328

1693

1.95

28.22

1.5

1.4

120553.55

101286.38

e6/l

0.19

238

1155

(3022689) Creatine [Moles/volume] in Urine

143

521

2.75

27.91

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

16313

154198

1.16

27.60

3.5

3.3

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

231

1064

2.18

27.06

1.1

7.51

10.35

u/ml

0.56

185

(3036603) Volume of Urine

260

1259

2.08

26.78

1.5

1.6

2037.40

1979.47

0.41

252

1232

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

739

4844

1.54

26.76

1.8

2.3

36.64

38.33

g/l

10.51

647

4282

(3004616) Nuclear Ab [Presence] in Serum

453

2631

1.74

26.67

1.3

—

(40768443) Skin Pathology biopsy report

1198

8643

1.41

26.53

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

728

4766

1.54

26.51

1.9

2.3

0.00

0.03

g/l

3.27

667

4370

(37021550) Renin [Units/volume] in Plasma --upright

115

384

3.00

26.35

1.3

110.04

88.07

mu/l

0.31

293

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

259

1261

2.06

26.30

1.3

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

431

2479

1.75

26.26

1.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

199

873

2.29

26.26

1.5

5.12

3.62

0.67

193

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

430

2472

1.75

26.25

1.2

1.1

1.11

2.15

iu/ml

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

313

1632

1.93

26.18

3.2

2.8

—

(3002256) Pathology report gross observation

3233

26776

1.24

26.12

1.2

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1293

9493

1.38

25.80

2.5

2.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

960

6701

1.45

25.53

1.7

1.6

2.26

6.99

iu/ml

0.66

198

1355

(3048929) Epstein Barr virus Ab [Presence] in Serum

1080

7704

1.42

25.51

1.2

1.3

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

269

1345

2.01

25.41

1.6

1.4

5.64

5.50

mmol/l

1.09

252

1273

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

297

1539

1.94

25.32

1.4

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

297

1539

1.94

25.32

1.4

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

297

1539

1.94

25.32

1.4

1.8

—

(4034850) Laboratory test

921

6420

1.45

24.68

10.6

8.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

501

3055

1.65

24.63

1.4

1.7

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

111

378

2.95

24.60

1.4

—

(36660697) Celiac disease serology panel - Serum

2256

18053

1.27

24.50

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

500

3054

1.65

24.42

1.4

1.7

—

(3042631) Mycobacterium sp identified in Specimen

393

2251

1.76

24.34

2.3

2.7

—

(3049717) Cytology report of Urine Cyto stain

867

6000

1.46

24.14

2.3

2.6

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

329

1794

1.84

24.01

2.6

3.3

58.07

56.36

0.80

276

1546

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

415

2425

1.72

23.95

1.5

—

(3011288) Drugs identified in Urine by Screen method

995

7076

1.42

23.92

2.5

3.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

8.34

23.10

5.0

6.1

0.21

0.22

mmol/l

0.04

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

959

6818

1.42

23.09

2.1

2.4

93.46

92.81

0.37

916

6546

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1029

7407

1.41

23.09

2.0

1.7

—

(3032057) Clostridioides difficile [Presence] in Stool

101

340

2.98

22.88

2.0

1.8

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

664

4406

1.52

22.77

1.8

2.4

0.00

g/l

0.11

604

4022

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1555

11966

1.32

22.72

2.8

3.2

37.68

46.32

u/ml

1.07

1490

11569

(3038026) Centromere Ab [Units/volume] in Serum

306

1661

1.85

22.69

1.2

46.92

50.46

u/ml

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

106

370

2.87

22.51

1.3

1.7

—

(3002079) Sodium [Moles/time] in 24 hour Urine

201

947

2.13

22.34

1.2

181.85

155.66

mmol/24h

3.58

201

947

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

548

3500

1.58

22.32

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

780

5379

1.46

22.14

1.4

127.18

113.71

pmol/l

0.42

749

5250

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

538

3430

1.58

22.09

1.1

—

(3045414) Leukocytes [Presence] in Urine

1232

9206

1.36

21.98

1.8

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

256

1326

1.94

21.93

1.6

1.5

—

(3051101) Glucose [Moles/volume] in Cord blood

241

3.33

21.84

6.1

5.5

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

652

4349

1.51

21.83

1.8

2.4

0.00

g/l

-0.00

598

4014

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

164

721

2.28

21.63

1.3

1.4

13.14

14.88

pmol/l

3.91

135

606

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

155

666

2.34

21.56

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

305

1687

1.82

21.32

1.5

2.2

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

296

1623

1.83

21.29

1.2

77.00

64.54

u/ml

0.26

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

296

1627

1.83

21.12

1.2

62.67

44.95

u/ml

0.44

128

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

680

4615

1.49

20.94

1.5

1.4

12.80

21.58

u/ml

2.03

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

127

510

2.50

20.53

3.4

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

127

510

2.50

20.53

3.4

2.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

810

5723

1.43

20.22

1.3

4.21

9.39

u/ml

4.60

111

922

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

265

1433

1.86

19.96

1.1

1.07

1.06

ratio

0.10

526

(3023487) Leukocytes [#/volume] in Peritoneal fluid

143

615

2.33

19.90

2.2

2.0

3878.79

3090.32

e6/l

0.08

422

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

679

4657

1.47

19.85

1.5

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

110

419

2.63

19.84

1.5

1.4

13.45

12.99

g/l

0.20

313

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

282

1564

1.81

19.59

1.2

6.58

9.23

u/ml

0.30

115

(3051593) INR in Capillary blood by Coagulation assay

148

653

2.27

19.41

11.7

9.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2213

18135

1.24

19.40

1.4

1.5

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

198

980

2.03

19.38

1.1

21.59

24.59

u/l

0.37

181

892

(40757494) Bilirubin.total [Moles/volume] in Blood

192

940

2.05

19.36

2.3

2.2

17.76

31.25

umol/l

1.12

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

288

2.96

19.12

3.9

4.8

68.26

39.31

ug/min

2.08

216

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

129

540

2.40

19.10

2.2

1.8

8184.48

11041.18

e6/l

0.27

288

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

792

5640

1.42

18.94

1.3

7.69

6.10

u/ml

0.24

604

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

862

6233

1.40

18.88

1.3

31.59

35.55

u/ml

0.11

398

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

197

984

2.01

18.81

1.1

79.99

83.71

u/l

0.36

182

895

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

199

999

2.00

18.74

1.2

1.3

354.29

416.14

titre

0.13

(3033799) Differential panel - Peritoneal fluid

127

534

2.39

18.63

2.3

1.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3576

30829

1.19

18.54

2.1

2.0

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

194

969

2.01

18.53

1.2

1.3

63.57

63.54

titre

0.00

(3013005) Retinol [Moles/volume] in Serum or Plasma

188

929

2.03

18.51

1.6

1.8

1.85

1.95

umol/l

1.23

181

869

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

866

6300

1.39

18.30

2.5

2.6

197.86

180.62

6.83

822

5976

(40762365) Oxygen content in Arterial blood by calculation

253

3.05

18.29

2.5

3.0

14.87

14.93

ml/dl

0.06

237

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

236

1273

1.86

17.97

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

328

2.75

17.74

2.1

2.7

117.11

30.72

mg/l

1.16

(3000093) Morphology [Interpretation] in Blood Narrative

292

1686

1.74

17.73

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

656

4570

1.45

17.73

1.2

1.3

3.33

4.80

u/ml

0.33

345

(1001926) Buprenorphine [Presence] in Urine by Screen method

1066

8053

1.34

17.71

2.1

2.2

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

181

899

2.02

17.59

1.4

445.46

710.92

mu/l

1.27

173

860

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

504

3336

1.52

17.59

1.1

124.68

117.60

4.98

449

3032

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

335

2016

1.67

17.48

1.6

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

620

4286

1.46

17.46

1.5

108.70

111.49

u/ml

0.33

155

942

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

646

4510

1.44

17.27

1.2

12.91

18.75

u/ml

0.20

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

367

2.62

17.26

1.2

0.61

79.05

mg/l

2.33

273

(3003338) MCHC [Mass/volume]

18102

187304

0.88

17.22

24.9

15.3

330.03

332.90

g/l

296.63

17977

186051

(3006576) Bicarbonate [Moles/volume] in Blood

133

594

2.25

17.02

7.9

6.2

25.88

25.00

mmol/l

1.38

123

546

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

186

948

1.97

16.83

1.4

2.1

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

182

921

1.98

16.81

1.4

72.43

72.92

0.17

174

882

(43055442) Apixaban [Mass/volume] in Serum or Plasma

169

3.44

16.78

1.6

1.5

107.69

114.68

ug/l

0.18

143

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

288

1687

1.72

16.65

1.1

1.2

155.00

187.59

titre

0.31

295

(3017315) Amylase [Enzymatic activity/volume] in Urine

206

1091

1.90

16.65

1.3

1.2

252.53

349.20

u/l

0.95

192

1006

(3002331) Protein [Mass/volume] in Peritoneal fluid

363

2.60

16.58

1.5

1.4

26.34

29.05

g/l

0.27

278

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

185

951

1.95

16.35

1.4

2.1

—

(3008898) HLA-B27 [Presence]

1111

8546

1.31

16.28

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

514

3475

1.49

16.24

1.3

1.6

0.68

0.75

g/l

0.93

388

2616

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

663

4705

1.42

16.23

1.2

1.3

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

285

1686

1.70

15.91

1.2

285.71

123.68

titre

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

580

4033

1.45

15.88

2.0

2.2

5.17

6.50

umol/l

2.23

430

2940

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1171

9113

1.30

15.75

1.1

1.03

12.10

u/ml

1.58

127

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

391

2.49

15.68

3.1

2.4

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

250

2.89

15.58

16.5

9.3

5.51

5.34

mmol/l

0.18

250

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

241

1371

1.77

15.49

2.0

1.9

2.40

2.01

u/field

0.47

104

644

(3018851) Theophylline [Moles/volume] in Serum or Plasma

121

3.81

15.49

1.6

1.9

47.48

45.39

umol/l

0.17

121

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

150

730

2.06

15.48

1.8

2.6

0.65

1.26

ug/l

5.34

137

696

(3020191) Ethanol [Moles/volume] in Serum or Plasma

288

1724

1.68

15.41

1.6

1.4

1.32

1.39

promille

0.39

226

1310

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

164

3.36

15.38

2.1

2.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

351

2211

1.60

15.33

1.3

1.4

6.48

6.82

g/l

1.09

242

1540

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

465

3120

1.50

15.28

1.3

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

350

2207

1.59

15.22

1.3

1.4

2.85

2.96

g/l

0.56

243

1535

(3024139) IgG subclass 3 [Mass/volume] in Serum

350

2208

1.59

15.19

1.3

1.4

0.42

0.40

g/l

0.14

243

1540

(4062490) Immunoglobulin typing, IgG

351

2219

1.59

15.10

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1910

15825

1.22

14.99

3.1

2.5

62.11

70.50

ml/min/173m2

14.57

939

5876

(3006922) Hepatitis E virus Ab [Presence] in Serum

262

1543

1.71

14.91

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

619

4420

1.41

14.67

1.3

278.45

266.08

u/ml

0.48

365

2912

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

212

1182

1.80

14.62

1.5

1.6

6.59

6.78

u/l

0.08

159

957

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

653

4715

1.40

14.51

1.2

1.3

4.10

3.67

mmol/l

14.40

609

4440

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

329

2.56

14.46

3.6

2.1

8.19

7.66

mmol/l

0.46

191

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

190

1035

1.84

14.15

1.6

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

3872

34280

1.15

13.98

2.2

2.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

262

1576

1.67

13.82

1.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1392

11260

1.25

13.66

1.1

245.63

225.48

titre

0.07

285

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

190

1047

1.82

13.65

1.1

101.11

95.48

1.59

145

846

(3019832) Treponema pallidum Ab [Presence] in Serum

3426

30126

1.16

13.54

1.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

157

816

1.93

13.53

3.3

3.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1391

11269

1.25

13.47

1.5

1.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

277

2.64

13.42

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

109

498

2.19

13.32

1.5

1.2

82.19

126.87

nmol/l

3.09

376

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

284

1763

1.62

13.25

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

496

3474

1.44

13.14

1.3

1.2

4.33

3.91

u/ml

0.29

219

1553

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

510

3592

1.43

13.11

1.3

1.2

3.79

3.67

u/ml

0.04

169

1245

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

176

961

1.84

13.05

1.9

2.4

22.06

195.61

ug/l

1.54

167

914

(3024263) Appearance of Synovial fluid

172

935

1.85

12.94

1.5

1.4

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

306

2.52

12.91

5.3

5.5

66.40

70.21

0.55

236

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

719

5375

1.35

12.91

1.3

1.4

550.49

508.02

mg/l

0.47

679

5143

(44813793) Dust mix specific IgE antibody measurement

269

1660

1.63

12.87

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

5726

52247

1.12

12.86

4.4

4.6

2.22

2.83

ug/l

1.18

5050

47364

(3011648) Oxygen content in Venous blood

240

1439

1.67

12.85

2.7

2.6

11.50

11.14

0.67

240

1439

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

291

1832

1.60

12.83

1.5

1.8

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

169

919

1.84

12.71

1.2

1.1

4.09

3.56

iu/ml

0.37

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

291

2.55

12.69

1.1

—

(3044007) Cell count panel - Peritoneal fluid

107

496

2.16

12.63

2.5

1.8

—

(3042733) HLA Ab [Presence] in Serum

140

719

1.95

12.54

4.8

4.9

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

810

6203

1.32

12.33

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

210

1230

1.71

12.29

1.2

1.5

6.94

7.92

ug/l

0.70

189

1116

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

205

2.83

12.25

2.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

136

698

1.95

12.22

1.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

213

3507

0.60

12.09

1.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

801

6147

1.31

12.02

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

234

1422

1.65

11.94

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

808

6219

1.31

11.87

1.2

—

(3003181) Sodium [Moles/volume] in Urine

404

2782

1.46

11.77

1.3

1.4

63.27

64.84

mmol/l

0.28

289

2220

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

575

4217

1.37

11.71

5.0

6.0

825.18

1348.19

iu/ml

0.52

631

(3026389) Candida sp identified in Specimen by Organism specific culture

457

3224

1.43

11.70

1.5

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

240

1476

1.63

11.70

3.3

2.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

234

1430

1.64

11.69

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

111

539

2.06

11.66

1.5

1.4

55.16

51.54

0.45

461

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

142

755

1.89

11.51

3.5

4.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

308

2017

1.53

11.48

1.5

1.8

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

197

1157

1.71

11.46

1.2

33.00

11.32

u/ml

0.31

133

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

249

1555

1.61

11.42

1.3

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

247

1546

1.60

11.23

1.3

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

106

515

2.06

11.14

1.4

1.2

36.95

39.88

g/l

1.13

265

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1470

12244

1.21

10.94

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

596

4447

1.35

10.91

1.3

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

717

9274

0.77

10.87

1.5

1.4

—

(3016879) Cocaine [Presence] in Urine

1188

9689

1.24

10.86

2.1

—

(40768446) Kidney Pathology biopsy report

148

815

1.82

10.78

1.6

1.7

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

317

2122

1.50

10.70

1.5

1.6

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

253

1612

1.58

10.69

1.2

1.3

1.02

1.76

u/ml

0.90

131

884

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

138

746

1.85

10.67

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

189

1121

1.69

10.64

1.2

1.3

78.79

85.88

u/l

0.62

166

976

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

182

2.81

10.63

1.1

1.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

138

747

1.85

10.62

1.5

2.3

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

185

1092

1.70

10.61

1.2

1.3

23.55

21.03

u/l

0.37

157

938

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

163

931

1.76

10.51

1.6

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

316

2123

1.49

10.49

1.5

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

139

760

1.83

10.38

1.5

2.3

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

142

782

1.82

10.36

6.2

5.5

2805.45

2779.81

mg/l

0.00

587

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

137

747

1.84

10.32

1.5

2.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

575

4310

1.34

10.24

1.7

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

226

2.57

10.22

2.7

2.5

0.91

1.18

mmol/l

0.44

157

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

839

6623

1.28

10.20

1.1

4.05

5.42

u/ml

0.66

959

(3000764) Benzodiazepines [Presence] in Urine

1265

10458

1.22

10.17

2.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

104

520

2.00

10.15

1.7

1.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

246

1578

1.56

10.13

1.1

—

(3036180) Methadone [Presence] in Urine

189

1139

1.66

10.05

2.0

2.4

—

(3027008) Opiates [Presence] in Urine

1270

10520

1.22

10.02

2.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

129

701

1.84

9.85

2.5

2.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

3965

43668

0.89

9.78

1.5

—

(3028300) Cannabinoids [Presence] in Urine

1270

10551

1.21

9.73

2.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

4.17

9.61

1.8

2.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

669

5173

1.30

9.58

1.3

1.2

—

(40768800) Prostate Pathology biopsy report

208

3253

0.64

9.57

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

161

945

1.71

9.48

1.6

1.5

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

296

2.30

9.46

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

442

3222

1.38

9.45

2.2

3.0

558.89

9832.41

u/ml

1.36

175

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

619

4753

1.31

9.35

1.4

1.5

1335.95

2700.03

e6/l

0.71

514

3872

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

618

4747

1.31

9.31

1.3

1.4

59.99

23.93

e6/l

0.84

486

3679

(3001729) Color of Synovial fluid

130

3.00

9.23

1.6

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

210

1334

1.58

9.08

2.1

99.42

97.71

0.32

193

1234

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

135

764

1.77

9.06

1.1

1.2

110.93

110.96

0.00

121

690

(3047352) Trisomy 18 risk [Likelihood] in Fetus

590

7633

0.77

9.02

1.6

1.4

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

346

2443

1.42

8.94

1.2

1.1

98.41

94.38

1.89

324

2296

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

144

834

1.73

8.93

1.1

1.2

0.32

0.30

g/l

3.01

120

676

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

150

2.80

8.81

2.5

2.0

66.08

59.53

0.50

(3043238) Trisomy 21 risk [Likelihood] in Fetus

609

7814

0.77

8.74

1.6

1.5

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

249

1661

1.50

8.65

1.1

1.3

2.11

1.99

mmol/l

0.62

231

1552

(3005033) Fetal Nuchal fold Thickness US

593

7620

0.77

8.62

1.5

1.4

—

(40762814) Titanium [Mass/volume] in Blood

246

2.36

8.60

2.3

2.4

3.80

3.64

ug/l

0.07

(3035611) Eosinophils/100 leukocytes in Synovial fluid

111

3.07

8.36

1.7

0.61

0.81

0.28

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

135

785

1.72

8.29

2.8

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1756

15227

1.16

8.26

2.4

2.3

24.43

22.48

au/ml

0.28

1360

(3041806) Other cells [#/volume] in Blood by Manual count

1149

0.44

8.17

1.5

—

(3017704) Immunofixation for Urine

146

875

1.67

8.04

1.2

1.8

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

823

6673

1.24

8.04

1.4

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

705

5625

1.26

7.94

1.2

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

923

7595

1.22

7.85

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

275

1912

1.44

7.80

1.5

33.45

33.94

g/l

0.26

254

1737

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

715

5727

1.26

7.80

1.8

1.9

16.20

14.53

iu/l

0.05

242

2241

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

116

2.93

7.78

2.5

2.1

11.56

16.21

0.58

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1618

14008

1.17

7.78

1.3

37.36

50.58

au/ml

1.35

715

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

274

1909

1.44

7.69

1.4

1.5

—

(3027035) Albumin [Mass/time] in 24 hour Urine

162

2.60

7.65

1.3

1.2

765.98

325.83

mg/24h

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

309

2206

1.41

7.58

1.2

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

162

1016

1.60

7.48

1.6

1.7

2.63

2.42

u/field

0.10

112

741

(3008295) Osmolality of Serum or Plasma

259

1796

1.45

7.47

1.5

285.36

280.25

mosm/kgh2o

2.88

197

1421

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

187

1213

1.55

7.47

1.0

1.1

3.17

6.50

nmol/l

0.76

235

(3024932) HLA-DR beta [Type]

123

719

1.71

7.46

1.0

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

296

2.13

7.39

1.4

1.3

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

120

699

1.72

7.38

1.1

2.47

7.90

u/ml

0.56

401

(3028433) Virus identified in Specimen by Culture

117

677

1.73

7.37

1.2

—

(3002619) Bacteria identified in Specimen by Culture

406

1.95

7.27

1.2

—

(3027944) Amphetamines [Presence] in Urine

1218

10363

1.18

7.27

2.0

—

(3006462) Nitrate [Presence] in Urine

155

972

1.60

7.19

3.5

2.8

—

(3023199) Leukocytes [#/volume] in Pleural fluid

249

1729

1.44

7.15

1.5

3403.90

3542.12

e6/l

0.03

192

1246

(3025549) Creatine [Moles/time] in 24 hour Urine

139

2.66

7.12

1.4

—

13.88

—

(3024471) HLA-A [Type]

124

737

1.69

7.10

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

257

1801

1.43

7.04

1.2

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

413

1.92

6.94

1.2

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

240

3411

0.70

6.93

2.9

3.6

25.16

34.47

u/ml

1.23

227

3297

(3004716) Salmonella sp identified in Stool by Organism specific culture

1413

12226

1.17

6.87

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

480

3723

1.29

6.86

1.5

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

3.88

6.69

1.4

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

945

7930

1.20

6.62

1.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

749

6146

1.23

6.61

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

116

2.76

6.61

1.9

1.3

351.91

297.28

umol/24h

0.67

116

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

164

2.44

6.48

1.4

1.3

0.73

1.80

ml/s/173m2

1.53

112

(3029634) Reagin Ab [Titer] in Serum by VDRL

423

3254

1.31

6.46

1.8

2.0

3.33

5.77

titre

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

595

4778

1.25

6.43

1.2

39.01

42.03

u/ml

0.15

475

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

249

1768

1.41

6.39

1.8

1.7

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

328

1.98

6.36

1.5

1.4

24.43

22.98

0.15

274

(40761539) Cells [Type] in Urine sediment by Light microscopy

469

1.82

6.35

1.3

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

197

1342

1.47

6.31

1.2

—

(40768793) Breast Pathology biopsy report

387

5029

0.77

6.25

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

132

826

1.60

6.24

1.1

—

(3011412) CD3 cells [#/volume] in Blood

286

2093

1.37

6.15

2.2

2.5

1.38

1.20

e9/l

2.96

264

1858

(3047189) Immunofixation for 24 hour Urine

123

761

1.62

6.10

1.5

1.9

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

423

3281

1.29

6.10

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

166

1105

1.51

5.99

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

486

1.77

5.97

1.5

2.0

20.74

35.68

u/l

1.12

434

(4281824) Cell count and differential, peritoneal fluid

298

2207

1.35

5.96

1.2

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

125

783

1.60

5.91

1.1

1.0

6.03

11.55

u/ml

3.18

445

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

118

2.63

5.87

1.3

1.2

122.41

100.41

ug/l

0.37

(3033923) Metanephrine [Moles/time] in 24 hour Urine

395

1.85

5.84

1.1

1.02

0.82

umol/24h

0.20

199

(3000919) Neutrophils/100 leukocytes in Pleural fluid

388

1.86

5.84

1.3

28.62

22.81

0.86

354

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

209

1473

1.42

5.65

1.1

7.41

8.60

iu/ml

0.50

377

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.03

5.63

1.2

1.4

522.80

494.03

nmol/l

0.09

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

316

1.93

5.59

1.1

1.0

0.03

0.21

u/ml

1.12

193

(3025577) Chromium [Mass/volume] in Blood

141

921

1.53

5.59

2.2

2.1

2.49

2.30

ug/l

0.19

114

767

(3014051) Protein [Presence] in Urine by Test strip

631

5186

1.22

5.56

2.7

2.3

—

(3010503) CD19 cells [#/volume] in Blood

182

1256

1.45

5.52

2.5

2.7

0.19

0.29

e9/l

0.65

176

1225

(21494814) CD8 cells/100 lymphocytes in Specimen

125

797

1.57

5.52

1.8

2.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

179

1233

1.45

5.49

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

567

1.68

5.47

1.7

1.6

11.49

8.60

ug/l

5.02

567

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

151

1006

1.50

5.47

2.2

2.1

202.79

196.55

u/l

0.62

151

997

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.14

5.45

1.0

—

(3035880) pH of Pleural fluid

122

776

1.57

5.45

1.2

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

220

1577

1.40

5.42

1.5

88708.25

47884.46

e6/l

0.98

129

938

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

185

1288

1.44

5.37

1.4

1.3

447.77

562.07

u/l

0.67

174

1228

(3034092) Cytoplasmic Ig cells/100 cells in Blood

245

2.04

5.37

8.9

6.4

—

(3051651) Icteric interference index of Serum or Plasma

169

1159

1.46

5.31

3.5

3.7

—

(3026470) Cobalt [Mass/volume] in Blood

143

948

1.51

5.31

2.1

2.0

5.18

3.21

ug/l

1.35

127

865

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

166

1135

1.47

5.30

1.1

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.71

5.25

1.0

0.02

0.07

u/ml

1.01

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

426

1.76

5.18

1.4

1.6

0.44

0.39

ug/l

0.62

287

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

204

1456

1.40

5.18

1.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

189

2.17

5.16

8.9

7.0

—

(3051611) Lipemic interference index of Serum or Plasma

260

1932

1.35

5.15

3.3

3.2

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

318

2434

1.31

5.14

2.4

2.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

981

8451

1.17

5.14

1.9

1.8

—

(3016038) Potassium [Moles/volume] in Urine

155

1056

1.47

5.06

1.1

1.3

30.24

35.03

mmol/l

2.16

126

923

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

213

1539

1.39

5.04

2.2

2.7

541.97

508.52

e6/l

0.51

189

1280

(4094501) Cardiovascular stress test using bicycle ergometer

638

5308

1.21

5.01

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

207

1498

1.39

4.87

2.3

2.7

0.24

0.23

e9/l

0.21

188

1279

(3016018) Differential panel - Cerebral spinal fluid

302

2314

1.31

4.87

1.3

1.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

450

3623

1.25

4.87

2.7

3.6

618.91

820.44

u/ml

0.24

404

3313

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

131

873

1.50

4.80

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

113

2.48

4.77

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

460

1.70

4.75

8.3

8.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

411

3286

1.25

4.74

1.2

—

(3025130) Human papilloma virus identified in Specimen

315

4041

0.78

4.72

1.6

1.7

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

428

3440

1.25

4.71

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

186

1330

1.40

4.71

1.6

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

3.02

4.66

1.1

187.67

211.75

pmol/l

0.15

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

123

815

1.51

4.64

2.2

2.8

184.28

157.56

au/ml

0.26

125

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

122

807

1.51

4.64

1.8

2.0

7.07

9.64

mg/l

6.41

652

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

184

1318

1.40

4.62

1.5

2.0

—

(3029612) Listeria sp Ab [Titer] in Serum

3.21

4.60

1.2

1.4

—

(3009015) Lactate [Moles/volume] in Synovial fluid

186

2.10

4.55

1.4

1.2

5.14

5.86

mmol/l

0.33

(3026250) Tacrolimus [Mass/volume] in Blood

143

984

1.46

4.49

36.4

35.6

7.32

7.40

ug/l

0.23

127

900

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

103

663

1.56

4.45

3.0

3.3

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

257

1.91

4.41

1.8

3.3

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

3.20

4.32

10.4

7.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

364

2907

1.26

4.28

2.3

2.5

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

283

1.84

4.20

1.2

1.53

1.76

mmol/l

0.59

171

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

151

1067

1.42

4.15

1.4

1.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

528

1.59

4.06

1.0

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1866

17012

1.10

4.05

1.5

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

128

884

1.45

4.00

2.6

2.5

51.24

51.15

umol/l

0.01

109

778

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

3.89

3.98

1.3

1.0

1.00

1.42

u/field

0.71

(3048879) Bone marrow aspiration report

477

1.62

3.96

1.4

2.1

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.53

3.95

1.0

0.01

0.05

u/ml

0.94

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

280

2192

1.28

3.93

1.0

1.1

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

219

1.92

3.89

1.1

1.3

—

60.80

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

349

2811

1.24

3.86

1.3

19.97

55.71

u/ml

3.97

197

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

103

687

1.50

3.84

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

412

1.65

3.83

8.6

8.3

—

(3052592) Norovirus Ag [Presence] in Stool

344

1.72

3.82

1.4

1.2

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

139

2.16

3.81

1.0

0.05

0.55

u/ml

1.47

125

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

128

893

1.44

3.81

2.6

3.3

7.99

8.11

mg/l

0.06

715

(37019676) Renin [Units/volume] in Plasma --supine

3.69

3.78

1.0

1.2

91.12

74.61

mu/l

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

600

5105

1.18

3.78

1.1

1.54

2.15

u/ml

1.28

327

2533

(3011325) HIV 1+2 Ab [Presence] in Serum

108

2.32

3.74

1.1

1.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2004

18409

1.10

3.73

3.3

4.1

19.12

24.19

ug/l

0.39

1597

14493

(3036782) Glucose [Moles/volume] in Pleural fluid

191

1430

1.34

3.73

1.3

6.81

6.20

mmol/l

2.27

172

1319

(3044009) aPTT.lupus sensitive (LA screen)

216

1.90

3.70

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

418

3452

1.21

3.66

1.1

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

3.11

3.64

11.7

6.6

45.11

49.45

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

207

1576

1.32

3.62

3.3

3.9

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

119

831

1.43

3.55

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.81

3.51

1.1

1.2

—

mmol/l

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

517

1.55

3.49

1.3

1.4

57.15

62.01

0.62

432

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

408

1.62

3.47

1.2

1.3

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

272

1.77

3.47

1.3

57.76

55.12

0.11

132

(3047007) Chlamydophila sp Ab [Presence] in Serum

418

3481

1.20

3.39

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

529

1.53

3.38

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1156

0.66

3.37

1.2

1.3

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

260

1.77

3.36

2.6

2.7

60.37

62.10

pmol/l

0.06

218

(3008401) Mugwort IgE Ab [Units/volume] in Serum

513

4357

1.18

3.35

1.1

0.82

1.16

u/ml

0.65

213

1831

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

644

1.48

3.33

1.7

201.88

108.65

au/ml

0.97

(3020393) Adenovirus Ag [Presence] in Stool

210

1.86

3.33

1.0

1.3

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

196

1.89

3.32

1.0

1.2

38.88

46.03

mg/l

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

524

1.53

3.31

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

536

4575

1.18

3.30

1.1

4.09

5.28

u/ml

1.31

279

2351

(40758358) Immune stain study

2.41

3.29

1.0

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

142

2.04

3.25

1.3

1.2

24.47

21.46

mmol/l

1.50

108

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

140

1025

1.37

3.22

1.4

1.3

12.65

14.02

u/l

0.53

130

950

(3011436) Histone Ab [Units/volume] in Serum

448

1.56

3.22

1.1

—

37.71

u/ml

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

544

1.51

3.21

1.2

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

457

1.56

3.19

1.4

1.3

38.33

40.79

0.18

303

(3002621) Streptococcal DNAse B [Units/volume] in Serum

185

1.89

3.17

1.0

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

434

1.57

3.17

1.3

1.4

1.51

2.85

1.45

370

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

586

5057

1.16

3.16

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

731

6410

1.14

3.16

2.8

3.6

1380.53

1551.69

u/ml

0.06

602

5508

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

266

1.73

3.13

1.1

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

114

1583

0.72

3.12

1.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

328

2693

1.22

3.11

1.2

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

672

1.45

3.08

1.4

1.5

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

257

2059

1.25

3.07

1.7

2.0

25.05

23.63

ug/l

0.11

252

2017

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.33

3.07

1.1

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

150

1120

1.34

3.06

1.8

2.0

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

145

1078

1.35

3.05

1.3

46.00

66.57

1.40

129

(21491868) Cryoglobulin [Mass/volume] in Serum

105

741

1.42

3.02

1.2

0.14

0.25

g/l

—

(3019174) dRVVT (LA screen)

210

1.81

3.02

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

297

2425

1.23

2.99

1.5

1.6

35.08

30.52

iu/ml

0.27

121

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

324

1.64

2.96

1.2

1.4

80.06

107.24

ng/l

0.37

202

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

107

2.15

2.95

1.0

1.1

34.44

62.71

u/l

1.22

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

212

1669

1.27

2.95

1.4

1.6

—

(3012441) Differential panel - Pleural fluid

192

1496

1.29

2.91

1.6

1.5

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

152

1148

1.33

2.90

1.8

1.7

147.53

136.84

1.04

143

1080

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

389

1.57

2.88

1.2

—

(3001218) Citrate [Mass/time] in 24 hour Urine

3.70

2.87

1.4

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

222

1.76

2.84

1.2

1.3

0.78

1.62

mmol/l

1.09

146

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.77

2.81

1.0

1.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

488

1.50

2.80

1.1

—

(3042517) Benzodiazepines panel - Urine

314

1.63

2.79

2.6

2.7

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

112

812

1.38

2.79

1.1

96.28

91.66

0.99

367

(3010370) Gastrin [Moles/volume] in Serum or Plasma

322

1.62

2.79

1.8

38.34

48.19

pmol/l

0.44

274

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

248

2004

1.24

2.78

1.1

1.2

44.64

40.12

mg/l

0.69

212

1674

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

241

1942

1.24

2.78

1.0

1.1

240.57

248.10

mg/l

0.22

210

1699

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

162

1243

1.31

2.78

1.7

1.4

6.49

5.74

u/l

0.35

141

1052

(3045788) Cell count panel - Pleural fluid

174

1349

1.29

2.76

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

196

1543

1.27

2.76

1.8

2.2

—

(3000219) Insulin receptor Ab [Presence] in Serum

8.33

2.75

1.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

106

769

1.38

2.65

3.0

2.3

133.89

154.46

nmol/l

1.60

671

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

267

2188

1.22

2.65

3.0

3.3

4.78

8.41

nmol/l

0.76

252

2125

(3010375) cycloSPORINE [Mass/volume] in Blood

127

950

1.34

2.62

27.5

27.4

116.14

118.81

ug/l

0.14

100

788

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

281

1.64

2.62

1.3

1.5

444741.48

258685.60

nmol/l

0.24

242

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

375

1.55

2.62

1.2

1.5

0.21

0.27

nmol/l

0.61

271

(3023410) Appearance of Cerebral spinal fluid

268

2200

1.22

2.62

1.4

1.6

—

(3003157) Bacteria [#/volume] in Mother's milk

2.46

2.61

4.3

7.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

524

1.45

2.54

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

129

973

1.33

2.53

1.1

1.2

—

(3027874) Urate [Moles/volume] in Urine

2.60

2.52

1.2

1.0

1.26

1.63

mmol/l

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

517

1.45

2.51

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

667

1.40

2.51

1.3

1.2

27.13

20.62

0.29

112

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

257

2115

1.22

2.47

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

109

2.02

2.45

2.3

2.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

351

4125

0.85

2.43

1.1

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

187

1490

1.26

2.43

1.6

1.9

4.60

3.46

mg/l

2.24

176

1421

(40762887) Creatinine [Moles/volume] in Blood

3.13

2.43

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

123

929

1.33

2.41

1.1

1.2

—

(40757373) Influenza virus identified in Isolate

360

1.53

2.38

1.6

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

258

1.63

2.37

1.2

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

717

1.37

2.37

1.6

1.8

5560.90

41095.80

u/ml

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

314

1.56

2.33

7.1

6.9

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

508

4453

1.14

2.31

1.4

0.33

0.44

nmol/l

2.93

399

3502

(3002523) Influenza virus A Ag [Presence] in Specimen

353

4124

0.85

2.30

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

126

1.91

2.29

1.2

1.0

10.21

10.48

u/l

0.03

126

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

229

1880

1.22

2.29

1.1

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.94

2.27

1.0

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

328

2786

1.18

2.27

1.7

1.6

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

2.55

2.26

1.0

142.50

455.95

u/l

1.04

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

156

1.80

2.24

1.4

7.49

16.43

pmol/l

1.38

131

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

216

1.67

2.24

1.2

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

142

1.83

2.22

1.2

—

(3051671) S100 calcium binding protein B [Mass/volume] in Serum

0.00

2.21

0.0

2.2

—

0.12

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

240

1.63

2.21

1.1

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

102

761

1.34

2.20

1.0

—

(3047185) IgG [Mass/volume] in Urine

2.68

2.20

1.1

1.0

—

45.20

—

(3035082) Kappa light chains [Mass/volume] in Urine

2.68

2.20

1.1

0.05

0.23

g/l

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

170

1358

1.25

2.20

1.1

1.25

1.04

u/l

0.49

583

(40768806) Pleura Pathology biopsy report

188

1522

1.24

2.16

1.6

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

435

1.45

2.14

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

226

1870

1.21

2.11

2.0

2.3

43.56

39.20

4.27

220

1835

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.36

2.11

1.0

1.2

1556.57

4542.03

ng/l

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

446

3904

1.14

2.11

1.2

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.90

2.07

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

168

1.73

2.06

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

261

1.57

2.05

1.2

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

144

1141

1.26

2.02

1.1

1528.82

1474.38

miu/ml

0.25

144

1141

(3027231) Wheat IgE Ab [Units/volume] in Serum

483

1.41

2.01

1.0

1.1

0.79

2.90

u/ml

0.83

404

(3016273) Islet cell 512 Ab [Units/volume] in Serum

162

1.73

2.01

1.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

958

8791

1.09

1.97

1.3

185.40

230.40

miu/ml

3.80

377

4292

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.28

1.97

1.0

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

119

1.85

1.96

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

128

1005

1.28

1.95

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

179

1.68

1.94

1.0

1.1

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

2.56

1.93

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

136

1.77

1.86

2.9

4.8

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

174

1.67

1.85

1.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

107

828

1.29

1.85

1.2

121.51

109.10

2.30

745

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

191

1.62

1.80

1.3

92.52

238.27

u/l

0.43

142

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

320

2776

1.15

1.78

1.7

7808.00

2649.36

titre

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

131

1.76

1.77

1.1

0.63

1.05

u/ml

0.23

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

137

1694

0.81

1.74

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

540

1.35

1.74

1.2

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2750

26301

1.05

1.72

1.5

1.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

190

1584

1.20

1.71

1.5

1.6

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

103

1.85

1.71

3.2

3.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

106

830

1.28

1.70

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

266

1.50

1.70

1.0

0.03

0.18

u/ml

1.92

149

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

373

1.42

1.70

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.06

1.69

1.1

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

127

1.73

1.63

1.2

1.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

188

1575

1.20

1.63

2.4

2.7

873.65

683.26

e6/l

4.67

181

1529

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

470

1.36

1.62

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

186

1558

1.20

1.61

1.3

1.4

13.51

11.43

umol/l

3.31

173

1485

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.69

1.58

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.69

1.58

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.69

1.58

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.69

1.58

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.69

1.58

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.69

1.58

2.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

101

797

1.27

1.55

1.1

101.45

93.16

1.33

367

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

129

1048

1.23

1.54

1.5

1.6

638405.00

1976021.76

iu/ml

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

169

1.60

1.51

1.0

2.44

1.17

u/ml

0.21

103

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.83

1.51

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

193

1.56

1.50

1.6

1.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

634

1.29

1.49

1.8

2.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

210

1.52

1.47

1.2

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

539

1.32

1.47

1.3

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1340

14216

0.94

1.46

1.6

1.7

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.22

1.46

2.0

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

4050

41807

0.96

1.45

3.9

4.0

22.78

21.68

3.55

1669

19481

(3012989) Citrate [Moles/time] in 24 hour Urine

2.37

1.45

2.7

1.2

1.99

2.15

mmol/24h

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

720

0.74

1.45

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

637

1.29

1.44

1.1

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

117

1.71

1.44

1.4

1.7

222.29

160.42

ug/g

0.71

101

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.88

1.44

1.6

1.5

0.00

0.08

u/l

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.73

1.43

1.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.03

1.43

1.0

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

104

835

1.25

1.41

1.1

436.92

469.90

ng/l

0.05

189

(3010726) Horse dander IgE Ab [Units/volume] in Serum

478

4327

1.11

1.40

1.1

1.43

2.01

u/ml

1.03

260

2123

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

380

4243

0.89

1.40

1.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

720

1.26

1.40

2.3

3.0

29.88

28.34

umol/l

0.72

558

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.25

1.40

1.0

2.0

2.56

2.37

mu/l

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

272

2383

1.14

1.39

1.2

—

(3014345) clomiPRAMINE [Moles/volume] in Serum or Plasma

2.94

1.36

1.6

4.1

389.00

251.35

nmol/l

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

248

1.45

1.34

1.0

1.1

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

1.34

0.0

2.2

—

18.78

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

367

1.36

1.32

2.1

4.8

47.68

57.17

u/l

0.62

358

(3001964) Herpes simplex virus Ag [Presence] in Specimen

655

1.27

1.32

1.4

1.5

—

(3035933) Granulocytes/100 leukocytes in Blood

684

0.75

1.31

1.5

1.7

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

121

1.65

1.30

1.3

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.35

1.29

1.0

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

284

1.41

1.28

1.0

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

169

1.54

1.28

1.0

1.1

—

2.21

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

161

1.55

1.28

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

1018

0.80

1.28

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

243

1.44

1.27

1.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

414

1.33

1.25

1.1

1.2

—

(3022475) Manganese [Moles/volume] in Blood

157

0.51

1.24

1.0

1.3

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

236

1.44

1.24

1.0

0.03

0.47

u/ml

1.87

126

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.91

1.22

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

381

1.34

1.22

1.5

1.2

417.31

323.99

ug/l

0.09

209

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

212

1.46

1.22

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

140

1.57

1.19

1.0

1.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.11

1.18

2.5

2.1

—

(3029075) Extractable nuclear Ab panel - Serum

684

1.24

1.18

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

515

1.28

1.17

2.3

2.7

91.95

111.34

ng/l

0.45

283

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

256

1.41

1.17

1.0

0.04

1.87

u/ml

0.62

125

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

102

838

1.22

1.17

1.9

1.8

181.97

155.47

1.52

792

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

408

3710

1.10

1.15

1.2

1.1

14.16

10.72

au/ml

0.34

259

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1179

0.82

1.15

1.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

105

867

1.21

1.15

1.6

2.2

24.50

29.22

3.61

105

819

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

208

1.44

1.12

1.3

1.1

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

250

1.40

1.12

1.0

5.99

1.68

u/ml

0.32

185

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.38

1.09

1.0

1.3

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

218

1.42

1.08

2.1

2.2

0.87

0.63

u/field

0.61

218

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

252

1.39

1.08

1.0

0.04

0.47

u/ml

1.08

132

(3050794) Legionella sp Ab [Presence] in Serum

169

1.48

1.06

1.1

1.2

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.12

1.05

1.0

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

296

1.35

1.05

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

113

1.59

1.05

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

824

0.80

1.03

1.0

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

570

1.25

1.03

1.5

1.6

—

464.40

iu/ml

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

162

1.48

1.03

1.0

0.05

1.73

u/ml

1.23

121

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

205

1.42

1.00

1.7

1.6

0.69

2.02

mg/l

2.60

129

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.00

1.00

2.1

5.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

231

1.39

0.99

1.1

—

(3049233) Organic acids panel - Urine

2.17

0.98

1.0

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

378

0.71

0.97

3.0

2.4

—

(3015183) Erythrocyte sedimentation rate

147

1276

1.15

0.95

1.3

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

968

9181

1.06

0.94

1.4

1.5

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.77

0.94

1.2

1.1

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

2.22

0.93

2.2

2.1

—

(3015350) Toxocara sp Ab [Presence] in Serum

2.22

0.93

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

113

963

1.17

0.93

1.1

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

243

1.36

0.92

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

420

1.26

0.89

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

358

1.29

0.89

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2950

30326

0.97

0.89

2.8

2.9

0.66

0.73

ug/l

3.91

1962

19277

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.61

0.87

1.1

1.4

—

(3020650) Glucose [Presence] in Urine

602

1.21

0.87

1.3

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

177

1568

1.13

0.87

1.2

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1566

16270

0.96

0.86

1.8

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

880

9268

0.95

0.86

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

882

9287

0.95

0.85

1.5

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

883

9292

0.95

0.84

1.5

1.4

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

129

1.47

0.83

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

275

1.31

0.81

1.4

1.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

267

1.31

0.80

1.1

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.82

0.79

1.0

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

428

4592

0.93

0.78

1.3

3.71

3.48

ug/l

0.28

389

4166

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

199

1.36

0.77

1.6

1.33

2.70

mg/l

0.96

139

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

199

1.36

0.77

1.6

0.83

0.96

mg/l

0.12

121

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

199

1.36

0.77

1.6

0.94

2.38

mg/l

2.29

134

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

199

1.36

0.77

1.6

0.54

1.98

mg/l

3.97

118

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

199

1.36

0.77

1.6

1.95

1.60

mg/l

0.20

144

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

199

1.36

0.77

1.6

3.16

3.89

mg/l

0.24

124

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

199

1.36

0.77

1.6

0.44

1.05

mg/l

1.30

132

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

199

1.36

0.77

1.6

1.17

2.31

mg/l

1.20

128

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

199

1.36

0.77

1.6

2.37

1.87

mg/l

0.20

143

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

658

6219

1.06

0.77

1.5

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

880

9232

0.95

0.76

1.5

1.4

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

349

1.26

0.76

1.2

1.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

140

1.43

0.76

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

166

1.39

0.75

1.1

—

(3041184) Isoniazid [Presence] in Urine

2.08

0.74

2.0

2.7

—

(3034614) HLA Ag [Interpretation]

1.64

0.73

1.0

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

108

1.48

0.73

1.1

1.9

—

(3041672) Baker's yeast Ab [Presence] in Serum

132

0.61

0.73

1.0

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

193

1.35

0.72

1.3

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2020

20803

0.97

0.72

1.9

—

(21494434) Karyotype in Bone marrow

166

1489

1.12

0.71

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

101

1.49

0.70

1.1

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

139

1237

1.12

0.68

1.2

1.3

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

528

1.19

0.68

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

528

1.19

0.68

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

528

1.19

0.68

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

528

1.19

0.68

1.1

—

(3017509) Phencyclidine [Presence] in Urine

293

1.26

0.67

2.1

1.7

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.63

0.66

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.54

0.66

1.4

1.3

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

127

1425

0.89

0.64

1.1

1.0

0.42

1.15

u/ml

0.78

328

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

251

1.28

0.63

1.0

4.34

1.31

u/ml

0.34

188

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

236

2171

1.09

0.63

4.0

4.7

157.46

106.28

u/ml

0.45

702

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

130

1454

0.89

0.63

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

373

3494

1.07

0.62

1.1

6.42

4.83

u/ml

0.40

159

1447

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

123

1095

1.12

0.62

1.2

1.3

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

403

0.79

0.62

1.5

1.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

152

1370

1.11

0.62

2.0

1.6

—

(3024869) Neuronal Ab [Presence] in Serum

351

1.23

0.62

1.0

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

164

1.34

0.62

1.2

14.56

15.26

nmol/l

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

130

1.38

0.61

1.0

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

209

0.72

0.59

1.9

2.8

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

201

1.29

0.58

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

383

3602

1.06

0.58

1.1

3.82

2.89

u/ml

0.46

155

1854

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

123

1.38

0.57

1.2

1.3

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

437

1.19

0.57

1.0

1.1

0.07

3.92

u/ml

1.99

305

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

195

1789

1.09

0.57

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

195

1790

1.09

0.57

1.2

—

(3014891) Appearance of Pleural fluid

167

1.32

0.56

1.4

1.3

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.51

0.56

1.3

1.2

1.65

1.34

4.72

(3007919) Fasciola sp Ab [Titer] in Serum

1.58

0.54

1.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

194

1786

1.09

0.54

1.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

213

1.27

0.53

1.4

1.3

13.56

13.08

0.03

109

(3000285) Sodium [Moles/volume] in Blood

213

1.27

0.53

1.1

—

(3008607) Semen analysis panel

1.43

0.52

1.3

—

(3045142) Bone marrow Pathology biopsy report

212

1964

1.08

0.51

1.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

196

1810

1.08

0.51

1.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

135

1.33

0.51

1.0

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

199

1841

1.08

0.50

1.5

1.4

24.26

32.64

nmol/l

5.09

176

1703

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

416

1.18

0.50

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.41

0.50

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

368

0.81

0.49

2.6

3.1

—

(40758292) HTLV I+II Ab panel - Serum

368

0.81

0.49

1.2

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

764

1.13

0.49

1.0

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

195

1806

1.08

0.49

1.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

367

0.82

0.48

5.1

6.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

195

1808

1.08

0.48

1.2

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

143

0.70

0.47

1.3

1.2

0.21

4.73

u/ml

—

119

(4035726) Immunohistochemistry procedure

1756

17153

1.03

0.47

1.4

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

155

1.29

0.46

1.0

1.1

16.80

16.28

iu/ml

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

166

1532

1.08

0.46

1.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.61

0.45

1.8

3.8

—

(3000060) B lymphocytes [#/volume] in Blood

674

1.13

0.45

1.5

2.3

330.00

312.38

e6/l

0.04

362

(3013762) Body weight Measured

0.60

0.45

1.0

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

174

1.26

0.44

1.2

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

1.37

0.43

1.1

1.2

—

10925.00

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

148

1.28

0.43

1.7

1.4

24.36

34.11

0.48

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

839

1.11

0.43

1.7

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

839

1.11

0.43

1.7

1.6

—

(3013293) Extractable nuclear Ab [Presence] in Serum

359

1.17

0.42

1.5

1.6

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

176

1.25

0.41

1.1

18.53

22.70

u/l

0.60

114

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.35

0.41

1.2

1.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

959

9874

0.97

0.41

1.5

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.41

0.0

1.0

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.41

0.0

1.1

—

(3018291) Platelet Ab [Presence] in Serum

1.47

0.40

1.2

1.0

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.40

0.0

1.8

—

15.33

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.36

0.40

1.2

1.0

19.79

21.20

0.50

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.36

0.40

1.1

1.0

8.03

8.75

0.55

(46235168) Fasting glucose [Moles/volume] in Blood

241

1.20

0.40

1.6

1.3

7.36

7.17

mmol/l

0.10

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

1.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

147

1365

1.08

0.38

1.2

—

(3006598) pH of Arterial cord blood

1.32

0.37

1.0

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

135

0.74

0.36

6.0

4.7

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

389

3730

1.04

0.35

1.1

5.71

4.27

u/ml

0.48

199

1751

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.64

0.35

1.8

3.7

—

(4212803) Bone marrow aspirate examination

153

1.24

0.35

1.2

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

404

0.87

0.33

2.1

2.4

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

265

1.17

0.33

2.4

2.6

—

(3020874) Milk IgE Ab [Units/volume] in Serum

166

1560

1.06

0.33

1.1

0.66

1.88

u/ml

1.99

493

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.30

0.33

1.3

1.1

—

(3013862) HLA-DP [Type]

0.68

0.33

1.0

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

511

1.12

0.32

1.2

67.00

71.79

0.18

131

(40768795) Lymph node Pathology biopsy report

187

1977

0.95

0.31

1.1

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

0.71

0.30

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

474

0.89

0.30

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

474

0.89

0.30

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

474

0.89

0.30

1.2

1.1

—

(3007733) Chloride [Moles/volume] in Urine

1.30

0.30

1.1

1.6

76.86

89.13

mmol/l

—

(3034426) Prothrombin time (PT)

812

1.08

0.29

1.3

1.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.25

0.29

1.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

173

0.81

0.28

2.6

3.8

2.73

2.23

mg/l

—

149

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

185

1947

0.95

0.28

3.4

3.8

50.11

45.56

u/ml

0.13

179

1934

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

139

0.79

0.26

1.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

145

1372

1.06

0.26

5.9

6.6

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

425

0.89

0.25

1.6

2.0

2.06

2.82

ug/l

0.49

244

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

313

3022

1.04

0.24

1.1

1.0

0.21

0.39

u/ml

0.92

102

773

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

512

1.09

0.24

1.2

1.1

102.43

83.68

1.62

134

(40760409) HLA-A [Type] by High resolution

0.71

0.24

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.71

0.24

1.0

—

(40760410) HLA-B [Type] by High resolution

0.71

0.24

1.0

—

(40763590) HLA-DQ beta [Type]

0.71

0.24

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

125

0.80

0.23

1.3

6.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

134

1.19

0.22

1.1

1.4

—

(3026726) Creatinine [Moles/volume] in Specimen

162

1.17

0.22

2.5

2.4

232.95

397.50

umol/l

0.74

155

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

483

0.91

0.22

1.1

1.3

—

(40765096) Chromosome analysis panel by Banding

524

0.92

0.21

1.1

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

0.00

0.21

0.0

2.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

201

1.14

0.21

1.0

1.1

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.21

0.0

1.8

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

0.20

0.0

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

759

0.94

0.20

1.0

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

155

0.84

0.20

1.5

2.6

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.21

0.19

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

127

1.18

0.19

1.0

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.21

0.18

1.0

—

(3009871) Measles virus Ab [Titer] in Serum

834

1.06

0.17

1.7

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

117

1224

0.96

0.17

2.3

2.8

43.83

39.64

1.86

666

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.22

0.17

14.9

14.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.74

0.17

1.0

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.14

0.16

1.0

1.1

212.87

239.60

nmol/l

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

162

0.86

0.16

1.0

1.1

6.41

7.23

u/ml

—

115

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

143

1378

1.04

0.15

1.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

328

0.91

0.15

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

217

1.11

0.14

1.2

1.4

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.83

0.13

1.4

1.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

120

1157

1.04

0.13

1.0

229.69

343.61

ng/l

2.93

829

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

120

1161

1.03

0.12

1.0

884.27

732.79

ng/l

2.74

806

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

858

8675

0.99

0.11

2.2

1.9

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

124

1.13

0.11

1.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

120

1163

1.03

0.11

1.0

30.58

41.08

ng/l

5.20

816

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

202

1.09

0.10

1.0

1.1

2.43

1.71

umol/24h

1.44

202

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

290

1.07

0.10

1.5

1.6

—

(3022670) pH of Venous cord blood

1.09

0.09

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

410

0.95

0.08

1.1

1.2

—

(3016031) Almond IgE Ab [Units/volume] in Serum

175

1.09

0.08

1.1

1.0

0.10

0.92

u/ml

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

226

0.93

0.08

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

841

8342

1.01

0.08

1.5

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.77

0.08

5.6

3.1

—

(3046861) Legionella sp Ag [Presence] in Urine

1.14

0.08

1.3

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

421

4260

0.99

0.08

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

746

1.03

0.08

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

307

0.94

0.07

1.1

1.2

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.08

0.07

1.6

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

143

0.91

0.07

1.2

1.1

—

(3007463) Buprenorphine [Presence] in Urine

112

0.89

0.07

6.3

7.9

—

(3030313) Adrenal Ab [Titer] in Serum

255

1.06

0.07

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

129

1.09

0.05

1.0

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

415

0.96

0.05

1.1

1.2

0.35

0.68

u/ml

0.42

409

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

323

0.96

0.05

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

100

1018

0.98

0.04

6.1

6.2

5631.38

3872.76

u/ml

0.11

210

(3027974) Hepatitis B virus e Ag [Presence] in Serum

141

1.06

0.03

1.1

1.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

380

0.97

0.02

4.1

6.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

142

1.06

0.02

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

248

2465

1.01

0.02

1.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

232

1.03

0.02

3.0

2.9

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

117

0.94

0.01

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

154

1546

1.00

0.00

1.1

0.69

3.07

u/ml

2.37

364

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

155

1.03

0.00

1.0

5.23

16.14

u/ml

—

128

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

151

0.99

0.00

1.9

2.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

151

1514

1.00

0.00

1.5

1.3

117.41

171.47

pmol/l

3.08

151

1514

(3005011) Chlamydia sp Ab [Titer] in Serum

323

0.99

0.00

1.6

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

133

0.98

0.00

1.2

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

938

1.00

0.00

3.1

3.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

318

1.01

0.00

2.0

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.98

0.00

1.0

18.88

10.25

u/ml

—

(3025311) HLA-B [Type]

0.00

-0.00

0.0

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.00

-0.00

5.9

9.8

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.93

-0.00

1.0

1.1

—

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

0.00

-0.00

0.0

1.5

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.00

-0.00

1.0

1.2

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

4.6

—

140.80

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3016072) Theophylline [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3032642) Schistosoma sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

-0.00

0.0

1.1

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3020399) Glucose [Mass/volume] in Urine

0.00

-0.00

0.0

1.8

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

-0.00

0.0

2.5

—

4.00

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.00

-0.00

2.0

5.7

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

-0.00

0.0

1.5

—

(3015057) Respiratory syncytial virus Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_OBESITYCAL and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_OBESITYCAL	2.147 [1.93, 2.39]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.058

During the follow-up period (1.1.1998 — 31.12.2019), 6161 out of 66711 females with E4_OBESITYCAL died.

Males

Parameter	HR [95% CI]	p-value
E4_OBESITYCAL	2.061 [1.87, 2.28]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.011

During the follow-up period (1.1.1998 — 31.12.2019), 7553 out of 48217 males with E4_OBESITYCAL died.

Mortality risk

Mortality risk for people of age

years, who have E4_OBESITYCAL.

N-year risk	Females	Males
1	0.208%	0.501%
5	1.284%	2.372%
10	3.008%	5.888%
15	5.484%	11.39%
20	9.308%	18.689%

Relationships between endpoints

↥

Index endpoint: E4_OBESITYCAL – Obesity due to excess calories

GWS hits: 49

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Obesity due to excess calories

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints